DCAMKL2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A0MZ66 | S473 | Sugiyama | SHTN1 KIAA1598 | LGtLNKSTSSRsLKsLDPENsEtELERILRRRKVtAEADss |
| A4FU28 | S140 | Sugiyama | CTAGE9 | AAAEEARSLEATCEKLSRsNsELEDEILCLEKDLKEEKSKH |
| A5A3E0 | T789 | Sugiyama | POTEF A26C1B | YPMEHGIITNWDDMEKIWHHtFyNELRVAPEEHPVLLTEAT |
| O00170 | T48 | Sugiyama | AIP XAP2 | FQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELIIGKKF |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14979 | T165 | Sugiyama | HNRNPDL HNRPDL JKTBP | QDDGKMFIGGLSWDTsKKDLtEyLSRFGEVVDCtIKTDPVT |
| O15078 | S1159 | Sugiyama | CEP290 BBS14 KIAA0373 NPHP6 | LELEKNEMELKVEVSKLREIsDIARRQVEILNAQQQSRDKE |
| O43390 | T134 | Sugiyama | HNRNPR HNRPR | KVQESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43423 | S100 | Sugiyama | ANP32CP PP32R1 | AEKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCE |
| O43491 | S529 | Sugiyama | EPB41L2 | LTLGSKFRYsGRTQAQTRQAsTLIDRPAPHFERTSSKRVsR |
| O43602 | S287 | Sugiyama | DCX DBCN LISX | DENECRVMKGNPSATAGPKAsPtPQKtSAKsPGPMRRsKsP |
| O43602 | T293 | Sugiyama | DCX DBCN LISX | VMKGNPSATAGPKAsPtPQKtSAKsPGPMRRsKsPADsGND |
| O43615 | S193 | Sugiyama | TIMM44 MIMT44 TIM44 | TAAFRALsQGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEF |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O60343 | T488 | Sugiyama | TBC1D4 AS160 KIAA0603 | IEGLYPPRAKLVIQRHLssLtDNEQADIFERVQKMKPVSDQ |
| O60506 | T131 | Sugiyama | SYNCRIP HNRPQ NSAP1 | KVADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60664 | S93 | Sugiyama | PLIN3 M6PRBP1 TIP47 | AAVsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQP |
| O60664 | T216 | Sugiyama | PLIN3 M6PRBP1 TIP47 | sEEWADNHLPLTDAELARIAtsLDGFDVAsVQQQRQEQSyF |
| O60739 | T45 | Sugiyama | EIF1B | AGTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKK |
| O60749 | S365 | Sugiyama | SNX2 TRG9 | AKSAAMLGNsEDHTALSRALsQLAEVEEKIDQLHQEQAFAD |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75369 | S1442 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | SKVKIAGPGLGsGVRARVLQsFtVDSSKAGLAPLEVRVLGP |
| O94804 | S514 | Sugiyama | STK10 LOK | ESMDYGTNLSTDLSLNKEMGsLsIKDPKLYKKTLKRTRKFV |
| O94804 | S516 | Sugiyama | STK10 LOK | MDYGTNLSTDLSLNKEMGsLsIKDPKLYKKTLKRTRKFVVD |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95218 | S153 | Sugiyama | ZRANB2 ZIS ZNF265 | KYRGKAVGPAsILKEVEDKEsEGEEEDEDEDLsKyKLDEDE |
| O95453 | S557 | Sugiyama | PARN DAN | KRLNPQCIPYTLQNHYYRNNsFtAPstVGKRNLsPsQEEAG |
| O95626 | S104 | Sugiyama | ANP32D PP32R2 | AEKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCE |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00558 | S174 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | LSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKEL |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02786 | S151 | Sugiyama | TFRC | LsEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVEN |
| P04040 | S515 | Sugiyama | CAT | ALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL________ |
| P04040 | T511 | Sugiyama | CAT | SHIQALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL____ |
| P04075 | S17 | Sugiyama | ALDOA ALDA | ____MPyQyPALtPEQKKELsDIAHRIVAPGKGILAADEst |
| P04075 | S176 | Sugiyama | ALDOA ALDA | EHtPsALAIMENANVLARyAsICQQNGIVPIVEPEILPDGD |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | T172 | Sugiyama | ANXA1 ANX1 LPC1 | INRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDF |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S312 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sstFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMA |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05362 | S43 | Sugiyama | ICAM1 | GPGNAQTSVSPSKVILPRGGsVLVTCstsCDQPKLLGIETP |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05783 | S93 | Sugiyama | KRT18 CYK18 PIG46 | GMGGIQNEKETMQsLNDRLAsyLDRVRSLETENRRLESKIR |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T55 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VPsGAstGIyEALELRDNDKtRYMGKGVSKAVEHINKtIAP |
| P06733 | Y200 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EAMRIGAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILEN |
| P06899 | S39 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07237 | S427 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | WDKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFP |
| P07237 | T453 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | EAVKVHsFPtLKFFPAsADRtVIDyNGERtLDGFKKFLESG |
| P07339 | S37 | Sugiyama | CTSD CPSD | PASALVRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQ |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07814 | T1506 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | LCELQPGAKCVCGKNPAKyytLFGRsy______________ |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S623 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tyGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsII |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P07900 | T305 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IDQEELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLA |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07900 | T467 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKEN |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S615 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tyGWTANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIV |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08238 | T297 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IDQEELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLA |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | T83 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sKLDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLG |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08238 | T94 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSGtKAFM |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09972 | S17 | Sugiyama | ALDOC ALDC | ____MPHSYPALSAEQKKELsDIALRIVAPGKGILAADEsV |
| P09972 | S176 | Sugiyama | ALDOC ALDC | ERTPSALAILENANVLARyAsICQQNGIVPIVEPEILPDGD |
| P0CG38 | T789 | Sugiyama | POTEI | YPMEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAP |
| P0CG39 | T752 | Sugiyama | POTEJ | YPMEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAP |
| P0CG41 | S140 | Sugiyama | CTAGE8 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P10809 | T61 | Sugiyama | HSPD1 HSP60 | LQGVDLLADAVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVA |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P11940 | T379 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | AtKPLyVALAQRKEERQAHLtNQyMQRMASVRAVPNPVINP |
| P12004 | S152 | Sugiyama | PCNA | EySCVVKMPSGEFARICRDLsHIGDAVVIsCAKDGVKFSAs |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12277 | S163 | Sugiyama | CKB CKBB | PPHCsRGERRAIEKLAVEALssLDGDLAGRyyALKsMtEAE |
| P12814 | T50 | Sugiyama | ACTN1 | EKQQRKTFTAWCNsHLRKAGtQIENIEEDFRDGLKLMLLLE |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S587 | Sugiyama | EEF2 EF2 | CIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKAR |
| P13639 | T484 | Sugiyama | EEF2 EF2 | VPCGNIVGLVGVDQFLVKtGtIttFEHAHNMRVMKFsVsPV |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S135 | Sugiyama | PDIA4 ERP70 ERP72 | IPVAKIDAtsAsVLAsRFDVsGyPtIKILKKGQAVDyEGsR |
| P13797 | S339 | Sugiyama | PLS3 | PRIDINMsGFNETDDLKRAEsMLQQADKLGCRQFVTPADVV |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13987 | T85 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | WKFEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGT |
| P14314 | S451 | Sugiyama | PRKCSH G19P1 | KLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMKyEQGtGC |
| P14314 | T444 | Sugiyama | PRKCSH G19P1 | VYRLCPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMK |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14625 | S172 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSELI |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P14625 | T519 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | DHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIy |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15880 | T202 | Sugiyama | RPS2 RPS4 | CKVTGRCGsVLVRLIPAPRGtGIVsAPVPKKLLMMAGIDDC |
| P15880 | T285 | Sugiyama | RPS2 RPS4 | PyQEFtDHLVKtHtRVsVQRtQAPAVATt____________ |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P17655 | T464 | Sugiyama | CAPN2 CANPL2 | TNIHLSKNFFLTNRARERsDtFINLREVLNRFKLPPGEYIL |
| P17980 | T163 | Sugiyama | PSMC3 TBP1 | EKLKPGDLVGVNKDSyLILEtLPtEyDsRVKAMEVDERPtE |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18858 | S901 | Sugiyama | LIG1 | DKQPEQATTSAQVACLYRKQsQIQNQQGEDsGsDPEDTY__ |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | T584 | Sugiyama | NCL | PNARSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARIVTDR |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P21333 | S2152 | Sugiyama | FLNA FLN FLN1 | VKVTGEGRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQ |
| P21333 | S2158 | Sugiyama | FLNA FLN FLN1 | GRVKEsITRRRRAPsVANVGsHCDLsLKIPEIsIQDMtAQV |
| P22059 | S240 | Sugiyama | OSBP OSBP1 | DLSTCNDLIAKHGTALQRsLsELEsLKLPAESNEKIKQVNE |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P23381 | S358 | Sugiyama | WARS1 IFI53 WARS WRS | TFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFs |
| P23381 | T301 | Sugiyama | WARS1 IFI53 WARS WRS | PAIQAAPSFSNSFPQIFRDRtDIQCLIPCAIDQDPyFRMTR |
| P23527 | S39 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P25054 | S2724 | Sugiyama | APC DP2.5 | QNVGNGSVPMRTVGLENRLNsFIQVDAPDQKGTEIKPGQNN |
| P25705 | S198 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GIIPRIsVREPMQTGIKAVDsLVPIGRGQRELIIGDRQTGK |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26373 | T24 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | SRNGMVLKPHFHKDWQRRVAtWFNQPARKIRRRKARQAKAR |
| P26447 | S14 | Sugiyama | S100A4 CAPL MTS1 | _______MACPLEKALDVMVstFHKYSGKEGDKFKLNKSEL |
| P26447 | T15 | Sugiyama | S100A4 CAPL MTS1 | ______MACPLEKALDVMVstFHKYSGKEGDKFKLNKSELK |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27816 | T828 | Sugiyama | MAP4 | AKtttAAAVAstGPssRsPstLLPKKPTAIKTEGKPAEVKK |
| P28066 | S159 | Sugiyama | PSMA5 | VALLFGGVDEKGPQLFHMDPsGtFVQCDARAIGsAsEGAQs |
| P28066 | T161 | Sugiyama | PSMA5 | LLFGGVDEKGPQLFHMDPsGtFVQCDARAIGsAsEGAQssL |
| P29401 | S305 | Sugiyama | TKT | LAtPPQEDAPsVDIANIRMPsLPsyKVGDKIATRKAYGQAL |
| P29401 | T442 | Sugiyama | TKT | GEDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAA |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P30040 | T62 | Sugiyama | ERP29 C12orf8 ERP28 | DtVtFyKVIPKSKFVLVKFDtQyPyGEKQDEFKRLAENSAS |
| P30086 | T167 | Sugiyama | PEBP1 PBP PEBP | GKFKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK |
| P30086 | T51 | Sugiyama | PEBP1 PBP PEBP | GAAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDP |
| P30101 | S474 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yFsPANKKLNPKKyEGGRELsDFIsyLQREAtNPPVIQEEK |
| P30101 | S98 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | VPLAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGP |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P32929 | S56 | Sugiyama | CTH | AVVPPISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVA |
| P33778 | S39 | Sugiyama | H2BC3 H2BFF HIST1H2BB | ITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKA |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35269 | T156 | Sugiyama | GTF2F1 RAP74 | EAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHFSI |
| P35579 | S1304 | Sugiyama | MYH9 | NVtGLLsQsDSKSSKLTKDFsALEsQLQDtQELLQEENRQK |
| P35579 | S1915 | Sugiyama | MYH9 | KLQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMA |
| P35579 | T1764 | Sugiyama | MYH9 | NtELINDRLKKANLQIDQINtDLNLERSHAQKNENARQQLE |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P37198 | S418 | Sugiyama | NUP62 | SQQKELEDLLsPLEELVKEQsGtIyLQHADEEREKTYKLAE |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38606 | S384 | Sugiyama | ATP6V1A ATP6A1 ATP6V1A1 VPP2 | RLAEMPADSGYPAyLGARLAsFYERAGRVKCLGNPEREGSV |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P38646 | T480 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | RNTTIPTKKSQVFstAADGQtQVEIKVCQGEREMAGDNKLL |
| P39687 | S104 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | AEKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCE |
| P39687 | T143 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | CEVtNLNDyRENVFKLLPQLtyLDGyDRDDKEAPDsDAEGY |
| P40818 | S718 | Sugiyama | USP8 KIAA0055 UBPY | AKPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtP |
| P40926 | T179 | Sugiyama | MDH2 | GVYNPNKIFGVTTLDIVRANtFVAELKGLDPARVNVPVIGG |
| P40939 | T418 | Sugiyama | HADHA HADH | DRGQQQVFKGLNDKVKKKALtSFERDSIFSNLTGQLDyQGF |
| P41091 | T21 | Sugiyama | EIF2S3 EIF2G | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| P41227 | T152 | Sugiyama | NAA10 ARD1 ARD1A TE2 | EVEPKyyADGEDAyAMKRDLtQMADELRRHLELKEKGRHVV |
| P41567 | T45 | Sugiyama | EIF1 SUI1 | AGTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKK |
| P42166 | T528 | Sugiyama | TMPO LAP2 | QVDRQLPSLACKYPVSSREAtQILSVPKVDDEILGFISEAT |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P43121 | T100 | Sugiyama | MCAM MUC18 | QGQSEPGEYEQRLsLQDRGAtLALtQVtPQDERIFLCQGKR |
| P43121 | T104 | Sugiyama | MCAM MUC18 | EPGEYEQRLsLQDRGAtLALtQVtPQDERIFLCQGKRPRSQ |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46783 | T148 | Sugiyama | RPS10 | RRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ___ |
| P46940 | S1448 | Sugiyama | IQGAP1 KIAA0051 | AIRDAKTPDKMKKsKsVKEDsNLtLQEKKEKIQTGLKKLTE |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P49368 | T484 | Sugiyama | CCT3 CCTG TRIC5 | tSLRAKHtQENCEtWGVNGEtGtLVDMKELGIWEPLAVKLQ |
| P49588 | S775 | Sugiyama | AARS1 AARS | VTGAEAQKALRKAESLKKCLsVMEAKVKAQTAPNKDVQREI |
| P49790 | S607 | Sugiyama | NUP153 | KtPPEDCEGPFRPAEILKEGsVLDILKsPGFAsPKIDSVAA |
| P50395 | T408 | Sugiyama | GDI2 RABGDIB | VPKDLGtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGsE |
| P50395 | T413 | Sugiyama | GDI2 RABGDIB | GtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGsEFDFEE |
| P50454 | S141 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | STARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHSKI |
| P50897 | S262 | Sugiyama | PPT1 CLN1 PPT | EWFGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVF |
| P50990 | S23 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | LHVPKAPGFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTT |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52597 | S265 | Sugiyama | HNRNPF HNRPF | EySGLSDGYGFTTDLFGRDLsyCLsGMyDHRYGDsEFtVQs |
| P52789 | S889 | Sugiyama | HK2 | PHFAKVMHETVKDLAPKCDVsFLQsEDGSGKGAALITAVAC |
| P52948 | S625 | Sugiyama | NUP98 ADAR2 | LNNsNLFsPVNRDsENLAsPsEyPENGERFsFLSKPVDENH |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53634 | T431 | Sugiyama | CTSC CPPI | GYGTDSASGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIE |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54105 | T36 | Sugiyama | CLNS1A CLCI ICLN | LLRQQPDTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSL |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P55196 | S216 | Sugiyama | AFDN AF6 MLLT4 | SRLAAEVYKDMPETSFTRtIsNPEVVMKRRRQQKLEKRMQE |
| P55854 | S27 | Sugiyama | SUMO3 SMT3A SMT3H1 | KEGVKTENDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | S198 | Sugiyama | TPI1 TPI | TPQQAQEVHEKLRGWLKsNVsDAVAQstRIIyGGsVtGAtC |
| P60174 | S204 | Sugiyama | TPI1 TPI | EVHEKLRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQ |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | T303 | Sugiyama | ACTB | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P60709 | T304 | Sugiyama | ACTB | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T89 | Sugiyama | ACTB | YPIEHGIVTNWDDMEKIWHHtFyNELRVAPEEHPVLLtEAP |
| P61081 | T176 | Sugiyama | UBE2M UBC12 | NRRLFEQNVQRSMRGGyIGstyFERCLK_____________ |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61353 | T94 | Sugiyama | RPL27 | VyNyNHLMPtRysVDIPLDKtVVNKDVFRDPALKRKARREA |
| P61956 | S28 | Sugiyama | SUMO2 SMT3B SMT3H2 | EGVKtENNDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62316 | T40 | Sugiyama | SNRPD2 SNRPD1 | EEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGRVKAFD |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T146 | Sugiyama | RPL8 | LARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANRAVV |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | T303 | Sugiyama | ACTG1 ACTG | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P63261 | T304 | Sugiyama | ACTG1 ACTG | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T89 | Sugiyama | ACTG1 ACTG | YPIEHGIVTNWDDMEKIWHHtFyNELRVAPEEHPVLLtEAP |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T91 | Sugiyama | ACTC1 ACTC | yPIEHGIItNWDDMEKIWHHtFyNELRVAPEEHPtLLTEAP |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T91 | Sugiyama | ACTA1 ACTA | yPIEHGIItNWDDMEKIWHHtFyNELRVAPEEHPtLLTEAP |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P78347 | S722 | Sugiyama | GTF2I BAP135 WBSCR6 | RtPtQtNGsNVPFKPRGREFsFEAWNAKITDLKQKVENLFN |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P98082 | S723 | Sugiyama | DAB2 DOC2 | DANQLLNKINEPPKPAPRQVsLPVTKstDNAFENPFFKDsF |
| Q00839 | T532 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | TWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtGKL |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q02790 | T42 | Sugiyama | FKBP4 FKBP52 | GVDIsPKQDEGVLKVIKREGtGTEMPMIGDRVFVHYTGWLL |
| Q02878 | T213 | Sugiyama | RPL6 TXREB1 | FVIAtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIF |
| Q02952 | S248 | Sugiyama | AKAP12 AKAP250 | KESEPKQSTEKPEETLKREQsHAEIsPPAESGQAVEECKEE |
| Q04760 | T35 | Sugiyama | GLO1 | AALSCCSDADPSTKDFLLQQtMLRVKDPKKSLDFyTRVLGM |
| Q04917 | T31 | Sugiyama | YWHAH YWHA1 | ARLAEQAERyDDMAsAMKAVtELNEPLsNEDRNLLsVAyKN |
| Q06323 | S55 | Sugiyama | PSME1 IFI5111 | KKIsELDAFLKEPALNEANLsNLKAPLDIPVPDPVKEKEKE |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q08AD1 | S464 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | FDKEDSVQRstPNRGITRsIsNEGLtLNNsHVsKHIRKNLS |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q12906 | S20 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | _MRPMRIFVNDDRHVMAKHssVyPTQEELEAVQNMVsHtER |
| Q13098 | S474 | Sugiyama | GPS1 COPS1 CSN1 | MLRAAVLRNQIHVKsPPREGsQGELtPANsQsRMstNM___ |
| Q13111 | S806 | Sugiyama | CHAF1A CAF CAF1P150 | PSEDAAIPSKSRLKRLISENsVYEKRPDFRMCWYVHPQVLQ |
| Q13136 | S338 | Sugiyama | PPFIA1 LIP1 | MEERITTLEKRYLAAQREATsVHDLNDKLENEIANKDSMHR |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13347 | T201 | Sugiyama | EIF3I EIF3S2 TRIP1 | LVNVKEHSRQINDIQLsRDMtMFVtASKDNTAKLFDsttLE |
| Q13442 | S63 | Sugiyama | PDAP1 HASPP28 | GGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDI |
| Q13596 | S368 | Sugiyama | SNX1 | AKSLAMLGSSEDNTALSRALsQLAEVEEKIEQLHQEQANND |
| Q13642 | T79 | Sugiyama | FHL1 SLIM1 | RFWHDtCFRCAKCLHPLANEtFVAKDNKILCNKCTTREDsP |
| Q13765 | T119 | Sugiyama | NACA HSD48 | SKNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAA |
| Q14118 | T522 | Sugiyama | DAG1 | HIDRVDAWVGTYFEVKIPSDtFyDHEDTTTDKLKLTLKLRE |
| Q14152 | S215 | Sugiyama | EIF3A EIF3S10 KIAA0139 | RKLCDNLRMHLsQIQRHHNQstAINLNNPESQsMHLETRLV |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14192 | T234 | Sugiyama | FHL2 DRAL SLIM3 | CDLyAKKCAGCTNPISGLGGtKyIsFEERQWHNDCFNCKKC |
| Q14257 | T301 | Sugiyama | RCN2 ERC55 | KKLsEEEILENPDLFLtsEAtDyGRQLHDDyFyHDEL____ |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14677 | S210 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | KNKSAFPFSDKLGELsDKIGstIDDtIsKFRRKDREDsPER |
| Q14966 | S1228 | Sugiyama | ZNF638 NP220 ZFML | DLEKKGAEIINPKTALLPSDsVFAEERNLKGILEEsPsEAE |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15084 | S389 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | FALLKGsFsEQGINEFLRELsFGRGstAPVGGGAFPtIVER |
| Q15172 | S472 | Sugiyama | PPP2R5A | EELWKKLEELKLKKALEKQNsAyNMHSILSNTSAE______ |
| Q15293 | T318 | Sugiyama | RCN1 RCN | EKLTKEEILENWNMFVGsQAtNyGEDLtKNHDEL_______ |
| Q15427 | T14 | Sugiyama | SF3B4 SAP49 | _______MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFL |
| Q15459 | S690 | Sugiyama | SF3A1 SAP114 | VHPPPPMEDEPTSKKLKTEDsLMPEEEFLRRNKGPVSIKVQ |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16531 | T1125 | Sugiyama | DDB1 XAP1 | MQEVVANLQYDDGSGMKREAtADDLIKVVEELtRIH_____ |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q16626 | S163 | Sugiyama | MEA1 MEA | RTMAGVSLPAPGVPAWAREIsDAQWEDVVQKALQARQAsPA |
| Q16719 | S443 | Sugiyama | KYNU | VVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAET |
| Q16719 | Y441 | Sugiyama | KYNU | RGVVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsA |
| Q16778 | S39 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKA |
| Q2VIR3 | T21 | Sugiyama | EIF2S3B | MAGGEAGVtLGQPHLsRQDLttLDVtKLTPLSHEVISRQAt |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q53H82 | T97 | Sugiyama | LACTB2 CGI-83 | HWHRDHSGGIGDICKSINNDtTyCIKKLPRNPQREEIIGNG |
| Q562R1 | T107 | Sugiyama | ACTBL2 | WYHTFYNELRVAPDEHPILLtEAPLNPKINREKMTQIMFEA |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | S488 | Sugiyama | HSP90AB3P HSP90BC | TYGWTANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIM |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q5BKZ1 | Y93 | Sugiyama | ZNF326 ZIRD | PYESyDsRsSLGGRDLYRsGyGFNEPEQSRFGGSYGGRFES |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5SSJ5 | S227 | Sugiyama | HP1BP3 | LKRELNRGVIKQVKGKGAsGsFVVVQKSRKTPQKSRNRKNR |
| Q5T035 | S66 | Sugiyama | FAM120A2P C9orf129 | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPI |
| Q5T035 | S68 | Sugiyama | FAM120A2P C9orf129 | EPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPINP |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6DN03 | S39 | Sugiyama | H2BC20P HIST2H2BC | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6DRA6 | S39 | Sugiyama | H2BC19P HIST2H2BD | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6EEV6 | S28 | Sugiyama | SUMO4 SMT3H4 | EEVKTENNNHINLKVAGQDGsVVQFKIKRQTPLSKLMKAYC |
| Q6P1J9 | S212 | Sugiyama | CDC73 C1orf28 HRPT2 | KKRSTIKTDLDDDITALKQRsFVDAEVDVTRDIVSRERVWR |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6S8J3 | T789 | Sugiyama | POTEE A26C1A POTE2 | YPMEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAP |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86UF2 | S140 | Sugiyama | CTAGE6 CTAGE6P | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q86WR0 | S187 | Sugiyama | CCDC25 | KKREKEEMKKKREMDELRSYssLMKVENMSSNQDGNDsDEF |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8IX94 | S140 | Sugiyama | CTAGE4 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q8IXH6 | S208 | Sugiyama | TP53INP2 C20orf110 DOR PINH | AVQRQNRARESRPRRSKNQSsFIyQPCQRQFNY________ |
| Q8N257 | S39 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | VTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKA |
| Q8N568 | S111 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | ISSDRFRSFDALLIELTRSLsDNVNLPQGVRtIytIDGsRK |
| Q8N568 | S129 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | SLsDNVNLPQGVRtIytIDGsRKVtsLDELLEGEsyVCASN |
| Q8N568 | S134 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | VNLPQGVRtIytIDGsRKVtsLDELLEGEsyVCASNEPFRK |
| Q8N568 | S143 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | IytIDGsRKVtsLDELLEGEsyVCASNEPFRKVDYTKNINP |
| Q8N568 | S166 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | CASNEPFRKVDYTKNINPNWsVNIKGGtsRALAAAssVKsE |
| Q8N568 | S174 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | KVDYTKNINPNWsVNIKGGtsRALAAAssVKsEVKESKDFI |
| Q8N568 | S181 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | INPNWsVNIKGGtsRALAAAssVKsEVKESKDFIKPKLVTV |
| Q8N568 | S182 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | NPNWsVNIKGGtsRALAAAssVKsEVKESKDFIKPKLVTVI |
| Q8N568 | S185 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | WsVNIKGGtsRALAAAssVKsEVKESKDFIKPKLVTVIRSG |
| Q8N568 | S223 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | RSGVKPRKAVRILLNKKtAHsFEQVLtDITEAIKLDSGVVK |
| Q8N568 | S286 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | FIACGPEKFRyAQDDFVLDHsECRVLKSSYSRSSAVKYSGS |
| Q8N568 | S362 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | PTsPGsFRGLKQISAHGRsssNVNGGPELDRCIsPEGVNGN |
| Q8N568 | S375 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | SAHGRsssNVNGGPELDRCIsPEGVNGNRCsESSTLLEKYK |
| Q8N568 | S385 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | NGGPELDRCIsPEGVNGNRCsESSTLLEKYKIGKVIGDGNF |
| Q8N568 | S442 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | LKIIDKAKCCGKEHLIENEVsILRRVKHPNIIMLVEEMETA |
| Q8N568 | S47 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | APSSSGGSSSSGPKGNGLIPsPAHsAHCsFyRTRtLQALSs |
| Q8N568 | S51 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | SGGSSSSGPKGNGLIPsPAHsAHCsFyRTRtLQALSsEKKA |
| Q8N568 | S55 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | SSSGPKGNGLIPsPAHsAHCsFyRTRtLQALSsEKKAKKAR |
| Q8N568 | S67 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | sPAHsAHCsFyRTRtLQALSsEKKAKKARFYRNGDRYFKGL |
| Q8N568 | T122 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | LLIELTRSLsDNVNLPQGVRtIytIDGsRKVtsLDELLEGE |
| Q8N568 | T125 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | ELTRSLsDNVNLPQGVRtIytIDGsRKVtsLDELLEGEsyV |
| Q8N568 | T133 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | NVNLPQGVRtIytIDGsRKVtsLDELLEGEsyVCASNEPFR |
| Q8N568 | T173 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | RKVDYTKNINPNWsVNIKGGtsRALAAAssVKsEVKESKDF |
| Q8N568 | T220 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | TVIRSGVKPRKAVRILLNKKtAHsFEQVLtDITEAIKLDSG |
| Q8N568 | T229 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | RKAVRILLNKKtAHsFEQVLtDITEAIKLDSGVVKRLCTLD |
| Q8N568 | T254 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | AIKLDSGVVKRLCTLDGKQVtCLQDFFGDDDVFIACGPEKF |
| Q8N568 | T485 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | LFLVMELVKGGDLFDAITSStKYTERDGSAMVYNLANALRY |
| Q8N568 | T61 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | GNGLIPsPAHsAHCsFyRTRtLQALSsEKKAKKARFYRNGD |
| Q8N568 | Y124 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | IELTRSLsDNVNLPQGVRtIytIDGsRKVtsLDELLEGEsy |
| Q8N568 | Y144 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | ytIDGsRKVtsLDELLEGEsyVCASNEPFRKVDYTKNINPN |
| Q8N568 | Y276 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | LQDFFGDDDVFIACGPEKFRyAQDDFVLDHsECRVLKSSYS |
| Q8N568 | Y57 | Sugiyama | DCLK2 DCAMKL2 DCDC3B DCK2 | SGPKGNGLIPsPAHsAHCsFyRTRtLQALSsEKKAKKARFY |
| Q8N6T3 | T292 | Sugiyama | ARFGAP1 ARF1GAP | VsQLAsKVQGVGSKGWRDVttFFsGKAEGPLDsPSEGHSyQ |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8ND56 | S368 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | EGNADEEDPLGPNCYYDKTKsFFDNIsCDDNRERRPtWAEE |
| Q8WVC0 | T477 | Sugiyama | LEO1 RDL | FDVYKAPLQGDHNHLFIRQGtGLQGQAVFKTKLTFRPHstD |
| Q8WWI1 | S704 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | KKRLMVERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEM |
| Q8WWI1 | S706 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | RLMVERLFQKIYGENGsKsMsDVsAEDVQNLRQLRYEEMQK |
| Q8WX93 | S479 | Sugiyama | PALLD KIAA0992 CGI-151 | VLECRVRGAPPLQVQWFRQGsEIQDsPDFRILQKKPRSTAE |
| Q92974 | T802 | Sugiyama | ARHGEF2 KIAA0651 LFP40 | sRDGEAGRAGAAPVAPEKQAtELALLQRQHALLQEELRRCR |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q93100 | S27 | Sugiyama | PHKB | LTAEVSWKVLERRARTKRsGsVyEPLKsINLPRPDNETLWD |
| Q96B36 | T233 | Sugiyama | AKT1S1 PRAS40 | PDLDRIAAsMRALVLREAEDtQVFGDLPRPRLNtsDFQKLK |
| Q96CT7 | S122 | Sugiyama | CCDC124 | DtLRRDHQLREAPDTAEKAKsHLEVPLEENVNRRVLEEGsV |
| Q96L92 | S51 | Sugiyama | SNX27 KIAA0488 My014 | AGNGGGGGGGPRVVRIVKsEsGYGFNVRGQVsEGGQLRSIN |
| Q96PK6 | S520 | Sugiyama | RBM14 SIP | AAAAYGAQPSATLAAPYRtQssAsLAAsYAAQQHPQAAASY |
| Q99613 | S754 | Sugiyama | EIF3C EIF3S8 | REHVVAASKAMKMGDWKTCHsFIINEKMNGKVWDLFPEADK |
| Q99613 | T880 | Sugiyama | EIF3C EIF3S8 | AEKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMR |
| Q99614 | S155 | Sugiyama | TTC1 TPR1 | AESSYSRALEMCPSCFQKERsILFSNRAAARMKQDKKEMAI |
| Q99615 | S94 | Sugiyama | DNAJC7 TPR2 TTC2 | MLGRFREALGDAQQsVRLDDsFVRGHLREGKCHLSLGNAMA |
| Q99733 | S53 | Sugiyama | NAP1L4 NAP2 | QNPRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALKQL |
| Q99733 | Y55 | Sugiyama | NAP1L4 NAP2 | PRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALKQLQV |
| Q99832 | T300 | Sugiyama | CCT7 CCTH NIP7-1 | KIHHSGAKVVLSKLPIGDVAtQyFADRDMFCAGRVPEEDLK |
| Q99832 | T351 | Sugiyama | CCT7 CCTH NIP7-1 | QtSVNALSADVLGRCQVFEEtQIGGERyNFFtGCPKAKTCt |
| Q99848 | S107 | Sugiyama | EBNA1BP2 EBP2 | APQNKDQKAVDPEDDFQREMsFyRQAQAAVLAVLPRLHQLK |
| Q99848 | Y109 | Sugiyama | EBNA1BP2 EBP2 | QNKDQKAVDPEDDFQREMsFyRQAQAAVLAVLPRLHQLKVP |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BT09 | T204 | Sugiyama | CNPY3 CTG4A ERDA5 PRAT4A TNRC5 HSPC084 UNQ1934/PRO4409 | HQEEDLTEFLCANHVLKGKDtsCLAEQWsGKKGDTAALGGK |
| Q9BYX7 | T89 | Sugiyama | POTEKP ACTBL3 FKSG30 | YPMEHGIITNWDDMEKIWHHtFyNELRVAPEEHPILLTEAP |
| Q9GZZ9 | S45 | Sugiyama | UBA5 UBE1DC1 | LQVPRSGDGGGGRVRIEKMssEVVDSNPysRLMALKRMGIV |
| Q9H2G2 | S341 | Sugiyama | SLK KIAA0204 STK2 | EDEEEEtENsLPIPAsKRAssDLsIAssEEDKLsQNACILE |
| Q9H2G2 | T527 | Sugiyama | SLK KIAA0204 STK2 | GEKEANIQAVDsEVGLTKEDtQEKLGEDDKTQKDVIsNtsD |
| Q9H3N1 | S270 | Sugiyama | TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268 | EAEsKEGtNKDFPQNAIRQRsLGPsLAtDKs__________ |
| Q9H788 | S129 | Sugiyama | SH2D4A PPP1R38 SH2A | EAEEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKDIWKKV |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQ39 | T159 | Sugiyama | RPS10P5 RPS10L | RRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ___ |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NUU7 | T21 | Sugiyama | DDX19A DDX19L | MATDSWALAVDEQEAAVKSMtNLQIKEEKVKADTNGIIKTS |
| Q9NUU7 | T467 | Sugiyama | DDX19A DDX19L | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9NZB2 | S417 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPI |
| Q9NZB2 | S419 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | EPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPINP |
| Q9NZL9 | S9 | Sugiyama | MAT2B TGR MSTP045 Nbla02999 UNQ2435/PRO4995 | ____________MVGREKELsIHFVPGsCRLVEEEVNIPNR |
| Q9UGV2 | T329 | Sugiyama | NDRG3 | FLQGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVts |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UI30 | S125 | Sugiyama | TRMT112 AD-001 HSPC152 HSPC170 | RMFPISRGIPNMLLsEEEtEs____________________ |
| Q9UKV8 | S387 | Sugiyama | AGO2 EIF2C2 | ATARSAPDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTD |
| Q9UKX7 | T235 | Sugiyama | NUP50 NPAP60L PRO1146 | VAAEtQsPsLFGstKLQQEStFLFHGNKTEDtPDKKMEVAS |
| Q9UMR2 | T468 | Sugiyama | DDX19B DBP5 DDX19 TDBP | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9UNH7 | S316 | Sugiyama | SNX6 | LKYYLRESQAAKDLLYRRsRsLVDYENANKALDKARAKNKD |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UQ35 | S1326 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | GGPHFsPEHKELsNsPLRENsFGsPLEFRNsGPLGTEMNtG |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ80 | T200 | Sugiyama | PA2G4 EBP1 | TPIEGMLSHQLKQHVIDGEKtIIQNPTDQQKKDHEKAEFEV |
| Q9Y2B0 | S116 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKFA |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y580 | S136 | Sugiyama | RBM7 | RyERTMDNMTSSAQIIQRsFssPENFQRQAVMNsALRQMSY |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 2.297141e-10 | 9.639 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.041195e-09 | 8.982 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.562311e-09 | 8.448 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.042584e-09 | 8.393 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.981221e-09 | 8.223 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.144057e-09 | 8.089 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.487017e-08 | 7.828 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.289972e-08 | 7.640 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.097216e-08 | 7.509 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.664108e-08 | 7.436 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.424502e-08 | 7.354 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.953081e-08 | 7.305 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.259984e-07 | 6.646 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.619995e-07 | 6.582 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.060190e-07 | 6.391 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.983032e-07 | 6.303 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.407893e-07 | 6.267 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 5.370150e-07 | 6.270 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.748694e-07 | 6.171 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.957308e-07 | 6.099 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.931687e-06 | 5.714 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.153332e-06 | 5.667 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.243800e-06 | 5.649 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.366219e-06 | 5.626 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.410663e-06 | 5.467 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.937230e-06 | 5.405 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.140880e-06 | 5.383 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.239341e-06 | 5.281 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.797841e-06 | 5.168 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.784782e-06 | 5.109 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.610997e-06 | 5.017 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.189138e-05 | 4.925 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.189138e-05 | 4.925 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.261967e-05 | 4.899 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.323330e-05 | 4.878 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.411043e-05 | 4.850 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.568989e-05 | 4.804 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.701143e-05 | 4.769 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.949651e-05 | 4.710 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.136531e-05 | 4.670 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.136531e-05 | 4.670 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.164019e-05 | 4.665 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.252670e-05 | 4.647 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.152314e-05 | 4.501 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.104633e-05 | 4.508 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.359934e-05 | 4.474 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.281748e-05 | 4.484 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.625542e-05 | 4.441 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.828813e-05 | 4.417 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.418317e-05 | 4.355 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.503253e-05 | 4.346 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.699260e-05 | 4.328 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.265152e-05 | 4.279 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.541052e-05 | 4.256 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.867791e-05 | 4.232 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.222719e-05 | 4.206 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.312909e-05 | 4.200 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.458847e-05 | 4.190 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 6.939501e-05 | 4.159 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.492667e-05 | 4.125 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.499188e-05 | 4.125 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 8.535985e-05 | 4.069 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.822603e-05 | 4.054 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 9.010342e-05 | 4.045 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.671228e-05 | 4.015 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.736786e-05 | 4.012 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.736786e-05 | 4.012 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.077472e-04 | 3.968 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.100221e-04 | 3.959 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.140415e-04 | 3.943 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.381132e-04 | 3.860 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.482151e-04 | 3.829 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.432181e-04 | 3.844 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.629080e-04 | 3.788 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.761149e-04 | 3.754 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.935828e-04 | 3.713 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.935828e-04 | 3.713 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.856673e-04 | 3.731 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.966681e-04 | 3.706 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.966681e-04 | 3.706 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.125269e-04 | 3.673 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.182506e-04 | 3.661 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.182506e-04 | 3.661 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.220100e-04 | 3.654 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.352444e-04 | 3.628 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.365535e-04 | 3.626 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.491780e-04 | 3.603 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.584646e-04 | 3.588 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.609755e-04 | 3.583 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.732390e-04 | 3.563 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.948603e-04 | 3.530 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.018030e-04 | 3.520 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.212537e-04 | 3.493 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.305321e-04 | 3.481 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.414115e-04 | 3.467 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.549189e-04 | 3.450 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.766013e-04 | 3.424 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.818510e-04 | 3.418 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.976446e-04 | 3.401 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.077892e-04 | 3.390 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.083786e-04 | 3.389 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.115668e-04 | 3.386 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.324680e-04 | 3.364 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.207892e-04 | 3.376 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.473525e-04 | 3.349 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.552993e-04 | 3.342 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.599488e-04 | 3.337 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.816982e-04 | 3.317 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.838113e-04 | 3.315 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.946338e-04 | 3.306 | 0 | 0 |
| Depurination | R-HSA-73927 | 5.188708e-04 | 3.285 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.521007e-04 | 3.258 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.081996e-04 | 3.216 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.125433e-04 | 3.213 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.695625e-04 | 3.174 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.708174e-04 | 3.173 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.733415e-04 | 3.172 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.051495e-04 | 3.152 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.944967e-04 | 3.158 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.255526e-04 | 3.139 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.255526e-04 | 3.139 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.822848e-04 | 3.107 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 8.160942e-04 | 3.088 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 8.474829e-04 | 3.072 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.401989e-04 | 3.027 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.224616e-04 | 3.035 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.662586e-04 | 3.015 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.420699e-04 | 3.026 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.204469e-03 | 2.919 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.204469e-03 | 2.919 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.206402e-03 | 2.919 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.016495e-03 | 2.993 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.092275e-03 | 2.962 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.249866e-03 | 2.903 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.063768e-03 | 2.973 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.115163e-03 | 2.953 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.092275e-03 | 2.962 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.020744e-03 | 2.991 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 9.960060e-04 | 3.002 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.216747e-03 | 2.915 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.152319e-03 | 2.938 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.223697e-03 | 2.912 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.223697e-03 | 2.912 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.109116e-03 | 2.955 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.154660e-03 | 2.938 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.200082e-03 | 2.921 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.200082e-03 | 2.921 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.200082e-03 | 2.921 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.985368e-04 | 3.001 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.117129e-03 | 2.952 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.167843e-03 | 2.933 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.069849e-03 | 2.971 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.235387e-03 | 2.908 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.092275e-03 | 2.962 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.259510e-03 | 2.900 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.386269e-03 | 2.858 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.386269e-03 | 2.858 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.446156e-03 | 2.840 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.512507e-03 | 2.820 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.587743e-03 | 2.799 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.605258e-03 | 2.794 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.685792e-03 | 2.773 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.777647e-03 | 2.750 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.777647e-03 | 2.750 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.777647e-03 | 2.750 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.777647e-03 | 2.750 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.777647e-03 | 2.750 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.959476e-03 | 2.708 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.959476e-03 | 2.708 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.987015e-03 | 2.702 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.987015e-03 | 2.702 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.038905e-03 | 2.691 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.121574e-03 | 2.673 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.185466e-03 | 2.660 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.269691e-03 | 2.644 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.333186e-03 | 2.632 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 2.385639e-03 | 2.622 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.526664e-03 | 2.597 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.570287e-03 | 2.590 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.912184e-03 | 2.536 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.679970e-03 | 2.572 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.671210e-03 | 2.573 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.634085e-03 | 2.579 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.912184e-03 | 2.536 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.888846e-03 | 2.539 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.888846e-03 | 2.539 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.641648e-03 | 2.578 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.956285e-03 | 2.529 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.966900e-03 | 2.528 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.001466e-03 | 2.523 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.003321e-03 | 2.522 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.145486e-03 | 2.502 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.196629e-03 | 2.495 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.196629e-03 | 2.495 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.409269e-03 | 2.467 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.258892e-03 | 2.487 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.582358e-03 | 2.446 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.647626e-03 | 2.438 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.647626e-03 | 2.438 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.794944e-03 | 2.421 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.865691e-03 | 2.413 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.870783e-03 | 2.412 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.986032e-03 | 2.399 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.201523e-03 | 2.377 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.218114e-03 | 2.375 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.240808e-03 | 2.373 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.397816e-03 | 2.357 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.428160e-03 | 2.354 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.457374e-03 | 2.351 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.457374e-03 | 2.351 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.545826e-03 | 2.342 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.748312e-03 | 2.323 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.058038e-03 | 2.296 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.093548e-03 | 2.293 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.548117e-03 | 2.256 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 5.786627e-03 | 2.238 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.553467e-03 | 2.255 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.553467e-03 | 2.255 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.553467e-03 | 2.255 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.582211e-03 | 2.253 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.147763e-03 | 2.211 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.688485e-03 | 2.245 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.169300e-03 | 2.210 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.553467e-03 | 2.255 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 6.213754e-03 | 2.207 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.761415e-03 | 2.239 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.533635e-03 | 2.257 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 6.256981e-03 | 2.204 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 6.416427e-03 | 2.193 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 6.416427e-03 | 2.193 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 6.444210e-03 | 2.191 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 6.715368e-03 | 2.173 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.746886e-03 | 2.171 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.969423e-03 | 2.157 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.013811e-03 | 2.154 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.124046e-03 | 2.147 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 7.124046e-03 | 2.147 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.124046e-03 | 2.147 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.124046e-03 | 2.147 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.414582e-03 | 2.130 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.638851e-03 | 2.117 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 7.684107e-03 | 2.114 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 7.684107e-03 | 2.114 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.777782e-03 | 2.109 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 8.338912e-03 | 2.079 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 8.016028e-03 | 2.096 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.183466e-03 | 2.037 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.183466e-03 | 2.037 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.344620e-03 | 2.079 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.280246e-03 | 2.082 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.280246e-03 | 2.082 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.897580e-03 | 2.103 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.016028e-03 | 2.096 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 7.883515e-03 | 2.103 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.982304e-03 | 2.047 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 8.303616e-03 | 2.081 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.100327e-03 | 2.091 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 8.747258e-03 | 2.058 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.747258e-03 | 2.058 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.344620e-03 | 2.079 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.389650e-03 | 2.076 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.722034e-03 | 2.012 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 9.722034e-03 | 2.012 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.010718e-02 | 1.995 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.020490e-02 | 1.991 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.027152e-02 | 1.988 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.029323e-02 | 1.987 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.030743e-02 | 1.987 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.075513e-02 | 1.968 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.117581e-02 | 1.952 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.121882e-02 | 1.950 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.121882e-02 | 1.950 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.121882e-02 | 1.950 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.192181e-02 | 1.924 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.195428e-02 | 1.922 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.221566e-02 | 1.913 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.241032e-02 | 1.906 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.243723e-02 | 1.905 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.412959e-02 | 1.850 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.386298e-02 | 1.858 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.269108e-02 | 1.897 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.269108e-02 | 1.897 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.484515e-02 | 1.828 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.501352e-02 | 1.824 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.437833e-02 | 1.842 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.297700e-02 | 1.887 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.420797e-02 | 1.847 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.489357e-02 | 1.827 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.510613e-02 | 1.821 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.504798e-02 | 1.823 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.452449e-02 | 1.838 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.318794e-02 | 1.880 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.412959e-02 | 1.850 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.501352e-02 | 1.824 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.515690e-02 | 1.819 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.519302e-02 | 1.818 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.525489e-02 | 1.817 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.525489e-02 | 1.817 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.527876e-02 | 1.816 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.584497e-02 | 1.800 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.608632e-02 | 1.794 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.624619e-02 | 1.789 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.777475e-02 | 1.750 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.799662e-02 | 1.745 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.799662e-02 | 1.745 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.799662e-02 | 1.745 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.818628e-02 | 1.740 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.830132e-02 | 1.738 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.864632e-02 | 1.729 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.864632e-02 | 1.729 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.948807e-02 | 1.710 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.014588e-02 | 1.696 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.014588e-02 | 1.696 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.017597e-02 | 1.695 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.030909e-02 | 1.692 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.066824e-02 | 1.685 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.119212e-02 | 1.674 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.181259e-02 | 1.661 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.205766e-02 | 1.656 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.205766e-02 | 1.656 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.205766e-02 | 1.656 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.205766e-02 | 1.656 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.205766e-02 | 1.656 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.214514e-02 | 1.655 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.224567e-02 | 1.653 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.224567e-02 | 1.653 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.254219e-02 | 1.647 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.257207e-02 | 1.646 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.265507e-02 | 1.645 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 2.265507e-02 | 1.645 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.280121e-02 | 1.642 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.414355e-02 | 1.617 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.487880e-02 | 1.604 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.487880e-02 | 1.604 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.496330e-02 | 1.603 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.559564e-02 | 1.592 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.654433e-02 | 1.576 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.397028e-02 | 1.469 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.397028e-02 | 1.469 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.397028e-02 | 1.469 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.397028e-02 | 1.469 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.397028e-02 | 1.469 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.397028e-02 | 1.469 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.397028e-02 | 1.469 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.397028e-02 | 1.469 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.397028e-02 | 1.469 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.397028e-02 | 1.469 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.397028e-02 | 1.469 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.838249e-02 | 1.547 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.192574e-02 | 1.496 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.192574e-02 | 1.496 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.756191e-02 | 1.560 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.726578e-02 | 1.564 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.726578e-02 | 1.564 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.349680e-02 | 1.475 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.252272e-02 | 1.488 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.809740e-02 | 1.551 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.145324e-02 | 1.502 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.967921e-02 | 1.528 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.728800e-02 | 1.564 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.149621e-02 | 1.502 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.134471e-02 | 1.504 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.804265e-02 | 1.552 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.890020e-02 | 1.539 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.838249e-02 | 1.547 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.289698e-02 | 1.483 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.192574e-02 | 1.496 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.993995e-02 | 1.524 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.857556e-02 | 1.544 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.828681e-02 | 1.548 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.828681e-02 | 1.548 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.967921e-02 | 1.528 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.726578e-02 | 1.564 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.410169e-02 | 1.467 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 3.410169e-02 | 1.467 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.430109e-02 | 1.465 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.430109e-02 | 1.465 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.430109e-02 | 1.465 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.430109e-02 | 1.465 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.430109e-02 | 1.465 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.430109e-02 | 1.465 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.544283e-02 | 1.450 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.544851e-02 | 1.450 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.544851e-02 | 1.450 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.574732e-02 | 1.447 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.574732e-02 | 1.447 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 3.574732e-02 | 1.447 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 3.574732e-02 | 1.447 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.574732e-02 | 1.447 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.574732e-02 | 1.447 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 3.574732e-02 | 1.447 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.637443e-02 | 1.439 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.678693e-02 | 1.434 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.721177e-02 | 1.429 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.777184e-02 | 1.423 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.781383e-02 | 1.422 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.841732e-02 | 1.415 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.841732e-02 | 1.415 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.846653e-02 | 1.415 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.919673e-02 | 1.407 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.003845e-02 | 1.398 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.045912e-02 | 1.393 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.122778e-02 | 1.385 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.169063e-02 | 1.380 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.181123e-02 | 1.379 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.222436e-02 | 1.374 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.222436e-02 | 1.374 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 4.850728e-02 | 1.314 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 4.850728e-02 | 1.314 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 4.850728e-02 | 1.314 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 4.850728e-02 | 1.314 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 4.850728e-02 | 1.314 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 4.850728e-02 | 1.314 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 4.850728e-02 | 1.314 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 4.850728e-02 | 1.314 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 4.850728e-02 | 1.314 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 5.852712e-02 | 1.233 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.852712e-02 | 1.233 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.339933e-02 | 1.272 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.339933e-02 | 1.272 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.339933e-02 | 1.272 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.339933e-02 | 1.272 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.579487e-02 | 1.339 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.579487e-02 | 1.339 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 4.579487e-02 | 1.339 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.046237e-02 | 1.297 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 5.046237e-02 | 1.297 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.046237e-02 | 1.297 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.213087e-02 | 1.283 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.732555e-02 | 1.325 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.839450e-02 | 1.234 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.513663e-02 | 1.345 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.513663e-02 | 1.345 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.551590e-02 | 1.256 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.256413e-02 | 1.279 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.256413e-02 | 1.279 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.353181e-02 | 1.271 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.353181e-02 | 1.271 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.696729e-02 | 1.328 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.692615e-02 | 1.245 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 5.036280e-02 | 1.298 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.707732e-02 | 1.244 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.513663e-02 | 1.345 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.626048e-02 | 1.250 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.626048e-02 | 1.250 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.479279e-02 | 1.349 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.626048e-02 | 1.250 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.732555e-02 | 1.325 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.579487e-02 | 1.339 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.677455e-02 | 1.330 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.551590e-02 | 1.256 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.630920e-02 | 1.334 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.820840e-02 | 1.235 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.707732e-02 | 1.244 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.100171e-02 | 1.292 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.852712e-02 | 1.233 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.540580e-02 | 1.343 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.839450e-02 | 1.234 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.933405e-02 | 1.307 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 5.339933e-02 | 1.272 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.750651e-02 | 1.240 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.015925e-02 | 1.300 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.579487e-02 | 1.339 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 4.933405e-02 | 1.307 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 4.732555e-02 | 1.325 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.683528e-02 | 1.245 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 5.339933e-02 | 1.272 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 5.339933e-02 | 1.272 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.077768e-02 | 1.216 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.077768e-02 | 1.216 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.077768e-02 | 1.216 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.095873e-02 | 1.215 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 6.095873e-02 | 1.215 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.097314e-02 | 1.215 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.106128e-02 | 1.214 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.106128e-02 | 1.214 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 6.168498e-02 | 1.210 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.168498e-02 | 1.210 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 6.168498e-02 | 1.210 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 6.168498e-02 | 1.210 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.175954e-02 | 1.209 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.175954e-02 | 1.209 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.241950e-02 | 1.205 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.241950e-02 | 1.205 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.241950e-02 | 1.205 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.325609e-02 | 1.199 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.328803e-02 | 1.199 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.328803e-02 | 1.199 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.328803e-02 | 1.199 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.429264e-02 | 1.192 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.458051e-02 | 1.190 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 6.458051e-02 | 1.190 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 6.458051e-02 | 1.190 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 6.458051e-02 | 1.190 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 6.458051e-02 | 1.190 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 6.458051e-02 | 1.190 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.459802e-02 | 1.190 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.468846e-02 | 1.189 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.468846e-02 | 1.189 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.525035e-02 | 1.185 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 6.526204e-02 | 1.185 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 6.652142e-02 | 1.177 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.715252e-02 | 1.173 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.806104e-02 | 1.167 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.815268e-02 | 1.167 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.815268e-02 | 1.167 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 6.847621e-02 | 1.164 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.847621e-02 | 1.164 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.954785e-02 | 1.158 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.979968e-02 | 1.156 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.979968e-02 | 1.156 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.000727e-02 | 1.155 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.051112e-02 | 1.152 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.272905e-02 | 1.138 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.426764e-02 | 1.129 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.500703e-02 | 1.125 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.500703e-02 | 1.125 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 7.589698e-02 | 1.120 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.589698e-02 | 1.120 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.589698e-02 | 1.120 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.672815e-02 | 1.115 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.926577e-02 | 1.101 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.926577e-02 | 1.101 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 7.964654e-02 | 1.099 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 8.031063e-02 | 1.095 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.031063e-02 | 1.095 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 8.031063e-02 | 1.095 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 8.031063e-02 | 1.095 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.088249e-02 | 1.092 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.088249e-02 | 1.092 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.088249e-02 | 1.092 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.382376e-02 | 1.077 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.474769e-02 | 1.072 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.602972e-02 | 1.065 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.662961e-02 | 1.062 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.727665e-02 | 1.059 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.727665e-02 | 1.059 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.760699e-02 | 1.057 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 8.932940e-02 | 1.049 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 8.932940e-02 | 1.049 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 8.932940e-02 | 1.049 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 8.932940e-02 | 1.049 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.990908e-02 | 1.046 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.990908e-02 | 1.046 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 9.177240e-02 | 1.037 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.177240e-02 | 1.037 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.247063e-02 | 1.034 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.424459e-02 | 1.026 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.424459e-02 | 1.026 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 9.757369e-02 | 1.011 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 9.757369e-02 | 1.011 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 9.757369e-02 | 1.011 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 9.757369e-02 | 1.011 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 9.757369e-02 | 1.011 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.254607e-01 | 0.901 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.002662e-01 | 0.999 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.002662e-01 | 0.999 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.002662e-01 | 0.999 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.015903e-01 | 0.993 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.015903e-01 | 0.993 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.015903e-01 | 0.993 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.015903e-01 | 0.993 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.015903e-01 | 0.993 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.253738e-01 | 0.902 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.193079e-01 | 0.923 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.193079e-01 | 0.923 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.193079e-01 | 0.923 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.193079e-01 | 0.923 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.123903e-01 | 0.949 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.123903e-01 | 0.949 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.414393e-01 | 0.849 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.414393e-01 | 0.849 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.053136e-01 | 0.978 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.315275e-01 | 0.881 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 9.839250e-02 | 1.007 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.220809e-01 | 0.913 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.132269e-01 | 0.946 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 1.401632e-01 | 0.853 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.292248e-01 | 0.889 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.292248e-01 | 0.889 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.292248e-01 | 0.889 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.105366e-01 | 0.956 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.248413e-01 | 0.904 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.099827e-01 | 0.959 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.123072e-01 | 0.950 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.924421e-02 | 1.003 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.368922e-01 | 0.864 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.020911e-01 | 0.991 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.414393e-01 | 0.849 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.434780e-01 | 0.843 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.300543e-01 | 0.886 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.300543e-01 | 0.886 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.356042e-01 | 0.868 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.123903e-01 | 0.949 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.434780e-01 | 0.843 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.281050e-01 | 0.892 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.156968e-01 | 0.937 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.345303e-01 | 0.871 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.839250e-02 | 1.007 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.328122e-01 | 0.877 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.345303e-01 | 0.871 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.002662e-01 | 0.999 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.905406e-02 | 1.004 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.116101e-01 | 0.952 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.360499e-01 | 0.866 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.136391e-01 | 0.944 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.289445e-01 | 0.890 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.123903e-01 | 0.949 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.384712e-01 | 0.859 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.413490e-01 | 0.850 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.307977e-01 | 0.883 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.173658e-01 | 0.930 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.292248e-01 | 0.889 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.193079e-01 | 0.923 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.154262e-01 | 0.938 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.254607e-01 | 0.901 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.253738e-01 | 0.902 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.253738e-01 | 0.902 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.351553e-01 | 0.869 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 1.254607e-01 | 0.901 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.289445e-01 | 0.890 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.050765e-01 | 0.978 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.742922e-02 | 1.011 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.414393e-01 | 0.849 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.282547e-01 | 0.892 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.201657e-01 | 0.920 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.053136e-01 | 0.978 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.073349e-01 | 0.969 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.253398e-01 | 0.902 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.345076e-01 | 0.871 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.289445e-01 | 0.890 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.442067e-01 | 0.841 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.447924e-01 | 0.839 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.449490e-01 | 0.839 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.459639e-01 | 0.836 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.463473e-01 | 0.835 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.463473e-01 | 0.835 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.464112e-01 | 0.834 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.464792e-01 | 0.834 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.464792e-01 | 0.834 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.464792e-01 | 0.834 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.464792e-01 | 0.834 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.464792e-01 | 0.834 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.466731e-01 | 0.834 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.507883e-01 | 0.822 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.507883e-01 | 0.822 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.507883e-01 | 0.822 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.507883e-01 | 0.822 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.514541e-01 | 0.820 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.514541e-01 | 0.820 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.514541e-01 | 0.820 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.514541e-01 | 0.820 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.514541e-01 | 0.820 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.514541e-01 | 0.820 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.522508e-01 | 0.817 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.539510e-01 | 0.813 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.539510e-01 | 0.813 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.553582e-01 | 0.809 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.553582e-01 | 0.809 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.553582e-01 | 0.809 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.553582e-01 | 0.809 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.553582e-01 | 0.809 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 1.553582e-01 | 0.809 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 1.553582e-01 | 0.809 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.561528e-01 | 0.806 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.561528e-01 | 0.806 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.571405e-01 | 0.804 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.589435e-01 | 0.799 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.594961e-01 | 0.797 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.594961e-01 | 0.797 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.602855e-01 | 0.795 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.602855e-01 | 0.795 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.602855e-01 | 0.795 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.602855e-01 | 0.795 | 0 | 0 |
| Defective SFTPA2 causes IPF | R-HSA-5687868 | 1.602855e-01 | 0.795 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.605863e-01 | 0.794 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.605863e-01 | 0.794 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.605863e-01 | 0.794 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.605863e-01 | 0.794 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.645431e-01 | 0.784 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.645431e-01 | 0.784 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.653061e-01 | 0.782 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.653061e-01 | 0.782 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.658631e-01 | 0.780 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 1.658631e-01 | 0.780 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.658631e-01 | 0.780 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.658631e-01 | 0.780 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.658631e-01 | 0.780 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.663671e-01 | 0.779 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.679876e-01 | 0.775 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 1.679876e-01 | 0.775 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.721037e-01 | 0.764 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.721037e-01 | 0.764 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.727027e-01 | 0.763 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.727027e-01 | 0.763 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.729252e-01 | 0.762 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.742000e-01 | 0.759 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.742000e-01 | 0.759 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.742000e-01 | 0.759 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.787342e-01 | 0.748 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.793086e-01 | 0.746 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.795800e-01 | 0.746 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.795800e-01 | 0.746 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.795800e-01 | 0.746 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.836486e-01 | 0.736 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.837497e-01 | 0.736 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.844975e-01 | 0.734 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.860776e-01 | 0.730 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.860776e-01 | 0.730 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.860776e-01 | 0.730 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.873866e-01 | 0.727 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.875095e-01 | 0.727 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.907398e-01 | 0.720 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.907398e-01 | 0.720 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.907398e-01 | 0.720 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.922163e-01 | 0.716 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.942144e-01 | 0.712 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.961904e-01 | 0.707 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.961904e-01 | 0.707 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.975096e-01 | 0.704 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.975096e-01 | 0.704 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.975096e-01 | 0.704 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.979264e-01 | 0.703 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.998524e-01 | 0.699 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.031601e-01 | 0.692 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.948873e-01 | 0.530 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 2.948873e-01 | 0.530 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 2.948873e-01 | 0.530 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.948873e-01 | 0.530 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.948873e-01 | 0.530 | 0 | 0 |
| Defective MOGS causes CDG-2b | R-HSA-4793954 | 2.948873e-01 | 0.530 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.948873e-01 | 0.530 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.178075e-01 | 0.662 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.819429e-01 | 0.550 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.819429e-01 | 0.550 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.819429e-01 | 0.550 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.819429e-01 | 0.550 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.819429e-01 | 0.550 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 2.551792e-01 | 0.593 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.551792e-01 | 0.593 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.551792e-01 | 0.593 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.551792e-01 | 0.593 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.456203e-01 | 0.461 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 3.456203e-01 | 0.461 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 3.456203e-01 | 0.461 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.094690e-01 | 0.679 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 2.094690e-01 | 0.679 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.094690e-01 | 0.679 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.020980e-01 | 0.520 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.020980e-01 | 0.520 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.020980e-01 | 0.520 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.020980e-01 | 0.520 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.020980e-01 | 0.520 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.020980e-01 | 0.520 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.683874e-01 | 0.571 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.683874e-01 | 0.571 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.408187e-01 | 0.618 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.175511e-01 | 0.662 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.455366e-01 | 0.610 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 2.733178e-01 | 0.563 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 2.733178e-01 | 0.563 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.733178e-01 | 0.563 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.069293e-01 | 0.513 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.069293e-01 | 0.513 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.069293e-01 | 0.513 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.069293e-01 | 0.513 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.493671e-01 | 0.457 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.493671e-01 | 0.457 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.493671e-01 | 0.457 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.493671e-01 | 0.457 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 4.073392e-01 | 0.390 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 4.073392e-01 | 0.390 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 4.073392e-01 | 0.390 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 4.073392e-01 | 0.390 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 4.073392e-01 | 0.390 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.073392e-01 | 0.390 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 4.073392e-01 | 0.390 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 4.073392e-01 | 0.390 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 4.073392e-01 | 0.390 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.073392e-01 | 0.390 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 4.073392e-01 | 0.390 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.038948e-01 | 0.691 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.241427e-01 | 0.649 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.744840e-01 | 0.561 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.066552e-01 | 0.513 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.066552e-01 | 0.513 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.066552e-01 | 0.513 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.066552e-01 | 0.513 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.066552e-01 | 0.513 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.475658e-01 | 0.606 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.459753e-01 | 0.461 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.736735e-01 | 0.563 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 3.041775e-01 | 0.517 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.962707e-01 | 0.402 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.962707e-01 | 0.402 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.962707e-01 | 0.402 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.962707e-01 | 0.402 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.962707e-01 | 0.402 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.962707e-01 | 0.402 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.962707e-01 | 0.402 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.717346e-01 | 0.566 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.717346e-01 | 0.566 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.717346e-01 | 0.566 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.450781e-01 | 0.611 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.405279e-01 | 0.468 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.006267e-01 | 0.522 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.006267e-01 | 0.522 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.006267e-01 | 0.522 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.006267e-01 | 0.522 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.188408e-01 | 0.660 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.965262e-01 | 0.528 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.344027e-01 | 0.476 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 3.344027e-01 | 0.476 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.850974e-01 | 0.414 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 3.850974e-01 | 0.414 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.380434e-01 | 0.623 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 2.921461e-01 | 0.534 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.144686e-01 | 0.669 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.876362e-01 | 0.541 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.218155e-01 | 0.492 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.156517e-01 | 0.501 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.740420e-01 | 0.562 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.096454e-01 | 0.509 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.096454e-01 | 0.509 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.096454e-01 | 0.509 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.096454e-01 | 0.509 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.474772e-01 | 0.459 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.395341e-01 | 0.469 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.956202e-01 | 0.403 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.733870e-01 | 0.428 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.830535e-01 | 0.548 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.463132e-01 | 0.461 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.279202e-01 | 0.484 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.589523e-01 | 0.445 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.679412e-01 | 0.434 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.994239e-01 | 0.399 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.981583e-01 | 0.526 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.320302e-01 | 0.479 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.830535e-01 | 0.548 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.470780e-01 | 0.460 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.290722e-01 | 0.483 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.938453e-01 | 0.532 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.486385e-01 | 0.604 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.966351e-01 | 0.528 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.041775e-01 | 0.517 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.935709e-01 | 0.405 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 3.493671e-01 | 0.457 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.050004e-01 | 0.688 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.094690e-01 | 0.679 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.962707e-01 | 0.402 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.876362e-01 | 0.541 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.493671e-01 | 0.457 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.746475e-01 | 0.426 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.066552e-01 | 0.513 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.259967e-01 | 0.487 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 2.094500e-01 | 0.679 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.819429e-01 | 0.550 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.405279e-01 | 0.468 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.994239e-01 | 0.399 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.280964e-01 | 0.484 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.055823e-01 | 0.515 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.455366e-01 | 0.610 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.501762e-01 | 0.602 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.819429e-01 | 0.550 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.819429e-01 | 0.550 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.551792e-01 | 0.593 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 3.456203e-01 | 0.461 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 2.683874e-01 | 0.571 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.175511e-01 | 0.662 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.219578e-01 | 0.654 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.493671e-01 | 0.457 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.473974e-01 | 0.607 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.936064e-01 | 0.405 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.218155e-01 | 0.492 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.924395e-01 | 0.534 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.611036e-01 | 0.442 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.041775e-01 | 0.517 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.994239e-01 | 0.399 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.429168e-01 | 0.615 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.280964e-01 | 0.484 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.991770e-01 | 0.399 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.453118e-01 | 0.462 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 3.459753e-01 | 0.461 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.779362e-01 | 0.556 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.395341e-01 | 0.469 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 3.107522e-01 | 0.508 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.328890e-01 | 0.633 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.178075e-01 | 0.662 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.456203e-01 | 0.461 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 3.456203e-01 | 0.461 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 3.850974e-01 | 0.414 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.857404e-01 | 0.544 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.485655e-01 | 0.605 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.490222e-01 | 0.457 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.466701e-01 | 0.608 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.235869e-01 | 0.651 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.490902e-01 | 0.604 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.094690e-01 | 0.679 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.897262e-01 | 0.409 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.610799e-01 | 0.442 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.649504e-01 | 0.438 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.069293e-01 | 0.513 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.073392e-01 | 0.390 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 3.066552e-01 | 0.513 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 3.962707e-01 | 0.402 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.021239e-01 | 0.396 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.236360e-01 | 0.650 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.744840e-01 | 0.561 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.218155e-01 | 0.492 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.962707e-01 | 0.402 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.320302e-01 | 0.479 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.547866e-01 | 0.450 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.785417e-01 | 0.555 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.463132e-01 | 0.461 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.890876e-01 | 0.410 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.921461e-01 | 0.534 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.066552e-01 | 0.513 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.466701e-01 | 0.608 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.522328e-01 | 0.598 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.717346e-01 | 0.566 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.101950e-01 | 0.677 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.094690e-01 | 0.679 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 3.020980e-01 | 0.520 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.175511e-01 | 0.662 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.175511e-01 | 0.662 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.493671e-01 | 0.457 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.493671e-01 | 0.457 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 4.073392e-01 | 0.390 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.962707e-01 | 0.402 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.118493e-01 | 0.674 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.280964e-01 | 0.484 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.219578e-01 | 0.654 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.066698e-01 | 0.513 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 3.459753e-01 | 0.461 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.746475e-01 | 0.426 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.425816e-01 | 0.465 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.740420e-01 | 0.562 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.475658e-01 | 0.606 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.805136e-01 | 0.420 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.493671e-01 | 0.457 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 3.405279e-01 | 0.468 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.551792e-01 | 0.593 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.493671e-01 | 0.457 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.352980e-01 | 0.628 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.805712e-01 | 0.552 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.558777e-01 | 0.449 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.466701e-01 | 0.608 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.276448e-01 | 0.643 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 3.069293e-01 | 0.513 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 3.069293e-01 | 0.513 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 3.459753e-01 | 0.461 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.627962e-01 | 0.580 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.589523e-01 | 0.445 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.880249e-01 | 0.411 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.004866e-01 | 0.397 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.455366e-01 | 0.610 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.830535e-01 | 0.548 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 3.456203e-01 | 0.461 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.733178e-01 | 0.563 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 4.073392e-01 | 0.390 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.344027e-01 | 0.476 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.962707e-01 | 0.402 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.408187e-01 | 0.618 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.969640e-01 | 0.401 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.179440e-01 | 0.498 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.547062e-01 | 0.450 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 4.079195e-01 | 0.389 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 4.079195e-01 | 0.389 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 4.079195e-01 | 0.389 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 4.079195e-01 | 0.389 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 4.079195e-01 | 0.389 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 4.079195e-01 | 0.389 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 4.079195e-01 | 0.389 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 4.079195e-01 | 0.389 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 4.079195e-01 | 0.389 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 4.079195e-01 | 0.389 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 4.079195e-01 | 0.389 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 4.079195e-01 | 0.389 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 4.079195e-01 | 0.389 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 4.079195e-01 | 0.389 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 4.079195e-01 | 0.389 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 4.079195e-01 | 0.389 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 4.079195e-01 | 0.389 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 4.079195e-01 | 0.389 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 4.079195e-01 | 0.389 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 4.079195e-01 | 0.389 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 4.079195e-01 | 0.389 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 4.079195e-01 | 0.389 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.079195e-01 | 0.389 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 4.079195e-01 | 0.389 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.079195e-01 | 0.389 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.083602e-01 | 0.389 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 4.087445e-01 | 0.389 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.087445e-01 | 0.389 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 4.087445e-01 | 0.389 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 4.087445e-01 | 0.389 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 4.087445e-01 | 0.389 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 4.087445e-01 | 0.389 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.124352e-01 | 0.385 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.124352e-01 | 0.385 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 4.127208e-01 | 0.384 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.236457e-01 | 0.373 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.239126e-01 | 0.373 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.239126e-01 | 0.373 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.239126e-01 | 0.373 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 4.239126e-01 | 0.373 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.239126e-01 | 0.373 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.239126e-01 | 0.373 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.239126e-01 | 0.373 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.254710e-01 | 0.371 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.254710e-01 | 0.371 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.254710e-01 | 0.371 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.282835e-01 | 0.368 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.301625e-01 | 0.366 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 4.301625e-01 | 0.366 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.334873e-01 | 0.363 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.342615e-01 | 0.362 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.368284e-01 | 0.360 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.368284e-01 | 0.360 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.368284e-01 | 0.360 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.368284e-01 | 0.360 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.368284e-01 | 0.360 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.368284e-01 | 0.360 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.368284e-01 | 0.360 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.400265e-01 | 0.357 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.400265e-01 | 0.357 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 4.400265e-01 | 0.357 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.422168e-01 | 0.354 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.422168e-01 | 0.354 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.422168e-01 | 0.354 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.422168e-01 | 0.354 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 4.422168e-01 | 0.354 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.422168e-01 | 0.354 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.422569e-01 | 0.354 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 4.425727e-01 | 0.354 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.425727e-01 | 0.354 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.425727e-01 | 0.354 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 4.425727e-01 | 0.354 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.454680e-01 | 0.351 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.514171e-01 | 0.345 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.514171e-01 | 0.345 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 4.514171e-01 | 0.345 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 4.620863e-01 | 0.335 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.620863e-01 | 0.335 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.620863e-01 | 0.335 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.620863e-01 | 0.335 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 4.660916e-01 | 0.332 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 4.660916e-01 | 0.332 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 4.660916e-01 | 0.332 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 4.660916e-01 | 0.332 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 4.660916e-01 | 0.332 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 4.660916e-01 | 0.332 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 4.660916e-01 | 0.332 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 4.660916e-01 | 0.332 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.695634e-01 | 0.328 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.695634e-01 | 0.328 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.701063e-01 | 0.328 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.759106e-01 | 0.322 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 4.759106e-01 | 0.322 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.765263e-01 | 0.322 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.770577e-01 | 0.321 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.771574e-01 | 0.321 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.852074e-01 | 0.314 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.865432e-01 | 0.313 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.865432e-01 | 0.313 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.867316e-01 | 0.313 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.867316e-01 | 0.313 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 4.954101e-01 | 0.305 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.978812e-01 | 0.303 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.993331e-01 | 0.302 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 4.993331e-01 | 0.302 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 4.993331e-01 | 0.302 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.993331e-01 | 0.302 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.993331e-01 | 0.302 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.993331e-01 | 0.302 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.025946e-01 | 0.299 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.025946e-01 | 0.299 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 5.028376e-01 | 0.299 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 5.028376e-01 | 0.299 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 5.028376e-01 | 0.299 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 5.028376e-01 | 0.299 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 5.028376e-01 | 0.299 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 5.028376e-01 | 0.299 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 5.028376e-01 | 0.299 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 5.028376e-01 | 0.299 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 5.028376e-01 | 0.299 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 5.028376e-01 | 0.299 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 5.028376e-01 | 0.299 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 5.028376e-01 | 0.299 | 0 | 0 |
| Influenza Virus Induced Apoptosis | R-HSA-168277 | 5.028376e-01 | 0.299 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 5.028376e-01 | 0.299 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 5.028376e-01 | 0.299 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 5.028376e-01 | 0.299 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 5.028376e-01 | 0.299 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 5.028376e-01 | 0.299 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 5.028376e-01 | 0.299 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 5.028376e-01 | 0.299 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.048928e-01 | 0.297 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.092409e-01 | 0.293 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.144607e-01 | 0.289 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.149626e-01 | 0.288 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 5.189820e-01 | 0.285 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.199407e-01 | 0.284 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 5.212427e-01 | 0.283 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 5.212427e-01 | 0.283 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 5.212427e-01 | 0.283 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 5.212427e-01 | 0.283 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.212427e-01 | 0.283 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.212427e-01 | 0.283 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.212427e-01 | 0.283 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 5.212427e-01 | 0.283 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.212427e-01 | 0.283 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 5.212427e-01 | 0.283 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 5.212427e-01 | 0.283 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.212427e-01 | 0.283 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.212427e-01 | 0.283 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 5.212427e-01 | 0.283 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.212427e-01 | 0.283 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.217367e-01 | 0.283 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.294496e-01 | 0.276 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.294496e-01 | 0.276 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.294496e-01 | 0.276 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.294496e-01 | 0.276 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.294496e-01 | 0.276 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.294496e-01 | 0.276 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.294496e-01 | 0.276 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.325017e-01 | 0.274 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.345681e-01 | 0.272 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.354163e-01 | 0.271 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.354163e-01 | 0.271 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.354163e-01 | 0.271 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.354163e-01 | 0.271 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.354163e-01 | 0.271 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 5.403630e-01 | 0.267 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.403630e-01 | 0.267 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 5.403630e-01 | 0.267 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.409839e-01 | 0.267 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.440448e-01 | 0.264 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.446976e-01 | 0.264 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.446976e-01 | 0.264 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.446976e-01 | 0.264 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.446976e-01 | 0.264 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 5.555613e-01 | 0.255 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.606910e-01 | 0.251 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.672469e-01 | 0.246 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.698515e-01 | 0.244 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.701021e-01 | 0.244 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.701021e-01 | 0.244 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.701021e-01 | 0.244 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.701021e-01 | 0.244 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.701021e-01 | 0.244 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.701456e-01 | 0.244 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.701456e-01 | 0.244 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.701456e-01 | 0.244 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.701456e-01 | 0.244 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.711679e-01 | 0.243 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.723589e-01 | 0.242 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 5.724373e-01 | 0.242 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 5.724373e-01 | 0.242 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 5.724373e-01 | 0.242 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 5.724373e-01 | 0.242 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 5.724373e-01 | 0.242 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 5.724373e-01 | 0.242 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 5.724373e-01 | 0.242 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 5.724373e-01 | 0.242 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 5.724373e-01 | 0.242 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 5.724373e-01 | 0.242 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 5.724373e-01 | 0.242 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 5.724373e-01 | 0.242 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 5.726563e-01 | 0.242 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.762334e-01 | 0.239 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 5.762334e-01 | 0.239 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 5.781455e-01 | 0.238 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.781455e-01 | 0.238 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.820260e-01 | 0.235 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.825437e-01 | 0.235 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.825437e-01 | 0.235 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 5.825437e-01 | 0.235 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.825437e-01 | 0.235 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.825437e-01 | 0.235 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.825437e-01 | 0.235 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 5.825437e-01 | 0.235 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 5.825437e-01 | 0.235 | 0 | 0 |
| Phenylketonuria | R-HSA-2160456 | 5.825437e-01 | 0.235 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.825437e-01 | 0.235 | 0 | 0 |
| Defective CYP1B1 causes Glaucoma | R-HSA-5579000 | 5.825437e-01 | 0.235 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.825437e-01 | 0.235 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.825437e-01 | 0.235 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 5.825437e-01 | 0.235 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.825437e-01 | 0.235 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.825437e-01 | 0.235 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 5.825437e-01 | 0.235 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.865836e-01 | 0.232 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.877739e-01 | 0.231 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.877739e-01 | 0.231 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.968670e-01 | 0.224 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 5.994352e-01 | 0.222 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.996466e-01 | 0.222 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.996466e-01 | 0.222 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.997398e-01 | 0.222 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.997398e-01 | 0.222 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 6.008622e-01 | 0.221 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.009868e-01 | 0.221 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 6.019382e-01 | 0.220 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.020030e-01 | 0.220 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.030070e-01 | 0.220 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.033734e-01 | 0.219 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.033734e-01 | 0.219 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.033734e-01 | 0.219 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.036642e-01 | 0.219 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 6.085045e-01 | 0.216 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.085045e-01 | 0.216 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.085045e-01 | 0.216 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 6.085045e-01 | 0.216 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.085045e-01 | 0.216 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.085045e-01 | 0.216 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.085045e-01 | 0.216 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 6.085045e-01 | 0.216 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.132482e-01 | 0.212 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.195264e-01 | 0.208 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.195264e-01 | 0.208 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.195264e-01 | 0.208 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.195264e-01 | 0.208 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 6.195264e-01 | 0.208 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.195264e-01 | 0.208 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 6.213939e-01 | 0.207 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 6.213939e-01 | 0.207 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.213939e-01 | 0.207 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.216406e-01 | 0.206 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.216760e-01 | 0.206 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.223938e-01 | 0.206 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.237026e-01 | 0.205 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.237026e-01 | 0.205 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.257656e-01 | 0.204 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.258711e-01 | 0.204 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.258711e-01 | 0.204 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.258711e-01 | 0.204 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 6.258711e-01 | 0.204 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.258711e-01 | 0.204 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.293542e-01 | 0.201 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.293542e-01 | 0.201 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.349921e-01 | 0.197 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.349921e-01 | 0.197 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.389140e-01 | 0.195 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.395099e-01 | 0.194 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.403483e-01 | 0.194 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 6.403604e-01 | 0.194 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.425332e-01 | 0.192 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.444279e-01 | 0.191 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.445443e-01 | 0.191 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.445443e-01 | 0.191 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 6.445443e-01 | 0.191 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.445443e-01 | 0.191 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.445443e-01 | 0.191 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.445443e-01 | 0.191 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 6.471315e-01 | 0.189 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 6.471315e-01 | 0.189 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.471315e-01 | 0.189 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 6.494749e-01 | 0.187 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 6.494749e-01 | 0.187 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 6.494749e-01 | 0.187 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 6.494749e-01 | 0.187 | 0 | 0 |
| Defective MAT1A causes MATD | R-HSA-5579024 | 6.494749e-01 | 0.187 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 6.494749e-01 | 0.187 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 6.494749e-01 | 0.187 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 6.494749e-01 | 0.187 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 6.494749e-01 | 0.187 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 6.494749e-01 | 0.187 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 6.494749e-01 | 0.187 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 6.494749e-01 | 0.187 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 6.494749e-01 | 0.187 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 6.494749e-01 | 0.187 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 6.494749e-01 | 0.187 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 6.494749e-01 | 0.187 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 6.494749e-01 | 0.187 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 6.494749e-01 | 0.187 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.565750e-01 | 0.183 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.565750e-01 | 0.183 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 6.565750e-01 | 0.183 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 6.575542e-01 | 0.182 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 6.625106e-01 | 0.179 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.625106e-01 | 0.179 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 6.625106e-01 | 0.179 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.625106e-01 | 0.179 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.625106e-01 | 0.179 | 0 | 0 |
| LTC4-CYSLTR mediated IL4 production | R-HSA-9664535 | 6.625106e-01 | 0.179 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 6.625106e-01 | 0.179 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.625106e-01 | 0.179 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 6.625106e-01 | 0.179 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.649289e-01 | 0.177 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.649289e-01 | 0.177 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.649289e-01 | 0.177 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 6.649289e-01 | 0.177 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 6.657103e-01 | 0.177 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.674244e-01 | 0.176 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.696791e-01 | 0.174 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.696791e-01 | 0.174 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 6.750469e-01 | 0.171 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.781691e-01 | 0.169 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.781691e-01 | 0.169 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.824764e-01 | 0.166 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 6.824764e-01 | 0.166 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.824764e-01 | 0.166 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.824764e-01 | 0.166 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.843005e-01 | 0.165 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.843005e-01 | 0.165 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.843005e-01 | 0.165 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.862098e-01 | 0.164 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 6.913125e-01 | 0.160 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 6.913125e-01 | 0.160 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.931425e-01 | 0.159 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 6.931425e-01 | 0.159 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.931425e-01 | 0.159 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.931425e-01 | 0.159 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.980115e-01 | 0.156 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 6.980115e-01 | 0.156 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.989329e-01 | 0.156 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 7.010709e-01 | 0.154 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.014955e-01 | 0.154 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.014955e-01 | 0.154 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 7.014955e-01 | 0.154 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.014955e-01 | 0.154 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.014955e-01 | 0.154 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 7.014955e-01 | 0.154 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.014955e-01 | 0.154 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.014955e-01 | 0.154 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.014955e-01 | 0.154 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.046092e-01 | 0.152 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 7.056782e-01 | 0.151 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 7.056782e-01 | 0.151 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 7.056782e-01 | 0.151 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 7.056782e-01 | 0.151 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 7.056782e-01 | 0.151 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 7.056782e-01 | 0.151 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 7.056782e-01 | 0.151 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 7.056782e-01 | 0.151 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 7.056782e-01 | 0.151 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 7.056782e-01 | 0.151 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 7.056782e-01 | 0.151 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 7.056782e-01 | 0.151 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 7.056782e-01 | 0.151 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 7.056782e-01 | 0.151 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 7.056782e-01 | 0.151 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.059032e-01 | 0.151 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.059032e-01 | 0.151 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.070287e-01 | 0.151 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 7.077051e-01 | 0.150 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 7.093752e-01 | 0.149 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 7.093752e-01 | 0.149 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 7.093752e-01 | 0.149 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.093752e-01 | 0.149 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.120085e-01 | 0.148 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.120085e-01 | 0.148 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.191630e-01 | 0.143 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.196182e-01 | 0.143 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.196182e-01 | 0.143 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.196182e-01 | 0.143 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.196182e-01 | 0.143 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.196182e-01 | 0.143 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 7.198622e-01 | 0.143 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 7.198622e-01 | 0.143 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.227929e-01 | 0.141 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.247738e-01 | 0.140 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.247738e-01 | 0.140 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.247738e-01 | 0.140 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 7.317527e-01 | 0.136 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 7.317527e-01 | 0.136 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 7.366585e-01 | 0.133 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 7.366585e-01 | 0.133 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.366585e-01 | 0.133 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 7.366585e-01 | 0.133 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.366585e-01 | 0.133 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.366585e-01 | 0.133 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 7.366585e-01 | 0.133 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 7.366585e-01 | 0.133 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.366585e-01 | 0.133 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.366585e-01 | 0.133 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 7.366585e-01 | 0.133 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.381987e-01 | 0.132 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.381987e-01 | 0.132 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.381987e-01 | 0.132 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 7.381987e-01 | 0.132 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.405894e-01 | 0.130 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.443645e-01 | 0.128 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.443645e-01 | 0.128 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.462880e-01 | 0.127 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.505385e-01 | 0.125 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.512852e-01 | 0.124 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.520494e-01 | 0.124 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.520494e-01 | 0.124 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 7.528725e-01 | 0.123 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 7.528725e-01 | 0.123 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 7.528725e-01 | 0.123 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 7.528725e-01 | 0.123 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 7.528725e-01 | 0.123 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 7.528725e-01 | 0.123 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 7.528725e-01 | 0.123 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 7.528725e-01 | 0.123 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 7.528725e-01 | 0.123 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 7.528725e-01 | 0.123 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 7.528725e-01 | 0.123 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 7.528725e-01 | 0.123 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 7.528725e-01 | 0.123 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 7.528725e-01 | 0.123 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 7.528725e-01 | 0.123 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 7.528725e-01 | 0.123 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 7.528725e-01 | 0.123 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.600129e-01 | 0.119 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.601133e-01 | 0.119 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.601937e-01 | 0.119 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.601937e-01 | 0.119 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.602565e-01 | 0.119 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.642843e-01 | 0.117 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.647060e-01 | 0.117 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.647060e-01 | 0.117 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.647060e-01 | 0.117 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.674085e-01 | 0.115 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.674085e-01 | 0.115 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.674085e-01 | 0.115 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.674085e-01 | 0.115 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.674085e-01 | 0.115 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.682227e-01 | 0.115 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.682227e-01 | 0.115 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 7.682227e-01 | 0.115 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.682227e-01 | 0.115 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 7.682227e-01 | 0.115 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.682227e-01 | 0.115 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.683668e-01 | 0.114 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.715864e-01 | 0.113 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.719746e-01 | 0.112 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.763787e-01 | 0.110 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.806021e-01 | 0.108 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.887934e-01 | 0.103 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.887934e-01 | 0.103 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.887934e-01 | 0.103 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.925015e-01 | 0.101 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 7.925015e-01 | 0.101 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.925015e-01 | 0.101 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 7.925015e-01 | 0.101 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.925015e-01 | 0.101 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 7.925015e-01 | 0.101 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 7.925015e-01 | 0.101 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.925015e-01 | 0.101 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 7.925015e-01 | 0.101 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 7.925015e-01 | 0.101 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 7.964379e-01 | 0.099 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 7.964379e-01 | 0.099 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 7.964379e-01 | 0.099 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.964379e-01 | 0.099 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 7.964379e-01 | 0.099 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 7.964379e-01 | 0.099 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 7.964379e-01 | 0.099 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 7.964379e-01 | 0.099 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.964379e-01 | 0.099 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.964379e-01 | 0.099 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 7.964379e-01 | 0.099 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 7.964379e-01 | 0.099 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.964379e-01 | 0.099 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.011854e-01 | 0.096 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.059096e-01 | 0.094 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.066337e-01 | 0.093 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.085743e-01 | 0.092 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.095753e-01 | 0.092 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.095753e-01 | 0.092 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.095753e-01 | 0.092 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 8.111469e-01 | 0.091 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.111469e-01 | 0.091 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.111469e-01 | 0.091 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.111469e-01 | 0.091 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.111469e-01 | 0.091 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.111469e-01 | 0.091 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.123997e-01 | 0.090 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.162065e-01 | 0.088 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.162065e-01 | 0.088 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 8.215665e-01 | 0.085 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.215665e-01 | 0.085 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.215665e-01 | 0.085 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.251689e-01 | 0.083 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.251689e-01 | 0.083 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 8.257775e-01 | 0.083 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 8.257775e-01 | 0.083 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 8.257775e-01 | 0.083 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 8.257775e-01 | 0.083 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 8.257775e-01 | 0.083 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 8.257775e-01 | 0.083 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 8.257775e-01 | 0.083 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 8.257775e-01 | 0.083 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 8.257775e-01 | 0.083 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 8.257775e-01 | 0.083 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 8.257775e-01 | 0.083 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 8.257775e-01 | 0.083 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 8.257775e-01 | 0.083 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 8.257775e-01 | 0.083 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 8.257775e-01 | 0.083 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 8.257775e-01 | 0.083 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.262073e-01 | 0.083 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.262073e-01 | 0.083 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.262073e-01 | 0.083 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.268161e-01 | 0.083 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.268161e-01 | 0.083 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.287332e-01 | 0.082 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.287834e-01 | 0.082 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.313043e-01 | 0.080 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.313043e-01 | 0.080 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.336761e-01 | 0.079 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.340156e-01 | 0.079 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.346878e-01 | 0.078 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.374274e-01 | 0.077 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.419440e-01 | 0.075 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.419440e-01 | 0.075 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.435820e-01 | 0.074 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.435907e-01 | 0.074 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.435907e-01 | 0.074 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.435907e-01 | 0.074 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.438726e-01 | 0.074 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.438726e-01 | 0.074 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 8.438726e-01 | 0.074 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.438726e-01 | 0.074 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.438726e-01 | 0.074 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.485701e-01 | 0.071 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.490043e-01 | 0.071 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.495834e-01 | 0.071 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 8.537187e-01 | 0.069 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 8.537187e-01 | 0.069 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 8.537187e-01 | 0.069 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 8.537187e-01 | 0.069 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 8.537187e-01 | 0.069 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 8.537187e-01 | 0.069 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 8.537187e-01 | 0.069 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 8.537187e-01 | 0.069 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 8.537187e-01 | 0.069 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 8.537187e-01 | 0.069 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.552378e-01 | 0.068 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.636151e-01 | 0.064 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.636151e-01 | 0.064 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.636151e-01 | 0.064 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.636151e-01 | 0.064 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.636151e-01 | 0.064 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.640107e-01 | 0.063 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.661118e-01 | 0.062 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 8.661118e-01 | 0.062 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 8.661118e-01 | 0.062 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.675871e-01 | 0.062 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.680056e-01 | 0.061 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.685057e-01 | 0.061 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.701915e-01 | 0.060 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.730473e-01 | 0.059 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.746370e-01 | 0.058 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.771802e-01 | 0.057 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.771802e-01 | 0.057 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 8.771802e-01 | 0.057 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 8.771802e-01 | 0.057 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 8.771802e-01 | 0.057 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 8.771802e-01 | 0.057 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.771802e-01 | 0.057 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 8.771802e-01 | 0.057 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.771802e-01 | 0.057 | 0 | 0 |
| Degradation of GABA | R-HSA-916853 | 8.771802e-01 | 0.057 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 8.771802e-01 | 0.057 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 8.771802e-01 | 0.057 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 8.771802e-01 | 0.057 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.771802e-01 | 0.057 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 8.771802e-01 | 0.057 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.784040e-01 | 0.056 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.790676e-01 | 0.056 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.810425e-01 | 0.055 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.810425e-01 | 0.055 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.812197e-01 | 0.055 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.858900e-01 | 0.053 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.896889e-01 | 0.051 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.900045e-01 | 0.051 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.944263e-01 | 0.048 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.944263e-01 | 0.048 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.952662e-01 | 0.048 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.963894e-01 | 0.048 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.963894e-01 | 0.048 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.968799e-01 | 0.047 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.968799e-01 | 0.047 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.968799e-01 | 0.047 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.968799e-01 | 0.047 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.968799e-01 | 0.047 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.968799e-01 | 0.047 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.968799e-01 | 0.047 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.968799e-01 | 0.047 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.968799e-01 | 0.047 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.968799e-01 | 0.047 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.968799e-01 | 0.047 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 8.968799e-01 | 0.047 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 8.968799e-01 | 0.047 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.972321e-01 | 0.047 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.975836e-01 | 0.047 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.975836e-01 | 0.047 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.976392e-01 | 0.047 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.996644e-01 | 0.046 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.996644e-01 | 0.046 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.027146e-01 | 0.044 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.064610e-01 | 0.043 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.085639e-01 | 0.042 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.098747e-01 | 0.041 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.098747e-01 | 0.041 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.098747e-01 | 0.041 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.098747e-01 | 0.041 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.098747e-01 | 0.041 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.098747e-01 | 0.041 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.098747e-01 | 0.041 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 9.098747e-01 | 0.041 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.121094e-01 | 0.040 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.121094e-01 | 0.040 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.127640e-01 | 0.040 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 9.134207e-01 | 0.039 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 9.134207e-01 | 0.039 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 9.134207e-01 | 0.039 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 9.134207e-01 | 0.039 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 9.134207e-01 | 0.039 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 9.134207e-01 | 0.039 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 9.134207e-01 | 0.039 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 9.134207e-01 | 0.039 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 9.134207e-01 | 0.039 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 9.134207e-01 | 0.039 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 9.134207e-01 | 0.039 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.162208e-01 | 0.038 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.172389e-01 | 0.038 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.172389e-01 | 0.038 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.177619e-01 | 0.037 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.178417e-01 | 0.037 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.178417e-01 | 0.037 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.196004e-01 | 0.036 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.217007e-01 | 0.035 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.217007e-01 | 0.035 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.217007e-01 | 0.035 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.245763e-01 | 0.034 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.265597e-01 | 0.033 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.265597e-01 | 0.033 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.265597e-01 | 0.033 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.265597e-01 | 0.033 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.267125e-01 | 0.033 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.268718e-01 | 0.033 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.268718e-01 | 0.033 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 9.273092e-01 | 0.033 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 9.273092e-01 | 0.033 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 9.273092e-01 | 0.033 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 9.273092e-01 | 0.033 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.288770e-01 | 0.032 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.298119e-01 | 0.032 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.320526e-01 | 0.031 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.320526e-01 | 0.031 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.320526e-01 | 0.031 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.344348e-01 | 0.029 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.356737e-01 | 0.029 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.372578e-01 | 0.028 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 9.389704e-01 | 0.027 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 9.389704e-01 | 0.027 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 9.389704e-01 | 0.027 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.389704e-01 | 0.027 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 9.389704e-01 | 0.027 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 9.389704e-01 | 0.027 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 9.389704e-01 | 0.027 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 9.389704e-01 | 0.027 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 9.389704e-01 | 0.027 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 9.389704e-01 | 0.027 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 9.389704e-01 | 0.027 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.410442e-01 | 0.026 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.410442e-01 | 0.026 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.410615e-01 | 0.026 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.410990e-01 | 0.026 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.410990e-01 | 0.026 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.410990e-01 | 0.026 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.410990e-01 | 0.026 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.410990e-01 | 0.026 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.413491e-01 | 0.026 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.415360e-01 | 0.026 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.415360e-01 | 0.026 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.431166e-01 | 0.025 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.475355e-01 | 0.023 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.480620e-01 | 0.023 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.487615e-01 | 0.023 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.487615e-01 | 0.023 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.487615e-01 | 0.023 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 9.487615e-01 | 0.023 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.487615e-01 | 0.023 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 9.487615e-01 | 0.023 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.489923e-01 | 0.023 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.534072e-01 | 0.021 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.558437e-01 | 0.020 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 9.558695e-01 | 0.020 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.558695e-01 | 0.020 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 9.569822e-01 | 0.019 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.569822e-01 | 0.019 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 9.569822e-01 | 0.019 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 9.569822e-01 | 0.019 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.569822e-01 | 0.019 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.569822e-01 | 0.019 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 9.569822e-01 | 0.019 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.582463e-01 | 0.019 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.588303e-01 | 0.018 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.588303e-01 | 0.018 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.599774e-01 | 0.018 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.599774e-01 | 0.018 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.599774e-01 | 0.018 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.613054e-01 | 0.017 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.616939e-01 | 0.017 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.618535e-01 | 0.017 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.618535e-01 | 0.017 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.618535e-01 | 0.017 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.618535e-01 | 0.017 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.618535e-01 | 0.017 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.618535e-01 | 0.017 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.618535e-01 | 0.017 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.618535e-01 | 0.017 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.618535e-01 | 0.017 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.628621e-01 | 0.016 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.631283e-01 | 0.016 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.633620e-01 | 0.016 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.633620e-01 | 0.016 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.634507e-01 | 0.016 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.638844e-01 | 0.016 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.638844e-01 | 0.016 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 9.638844e-01 | 0.016 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.638844e-01 | 0.016 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 9.638844e-01 | 0.016 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.638844e-01 | 0.016 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.638844e-01 | 0.016 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.638844e-01 | 0.016 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.638844e-01 | 0.016 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.638844e-01 | 0.016 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.670537e-01 | 0.015 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.670537e-01 | 0.015 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.692080e-01 | 0.014 | 0 | 0 |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | R-HSA-2142816 | 9.696795e-01 | 0.013 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.696795e-01 | 0.013 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.696795e-01 | 0.013 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 9.696795e-01 | 0.013 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.696795e-01 | 0.013 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 9.696795e-01 | 0.013 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.696795e-01 | 0.013 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.696795e-01 | 0.013 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.702233e-01 | 0.013 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.712800e-01 | 0.013 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.712800e-01 | 0.013 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.712800e-01 | 0.013 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.712800e-01 | 0.013 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.715677e-01 | 0.013 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.715677e-01 | 0.013 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.715677e-01 | 0.013 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.715677e-01 | 0.013 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.715677e-01 | 0.013 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.715677e-01 | 0.013 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.721560e-01 | 0.012 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.726780e-01 | 0.012 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.739157e-01 | 0.011 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.739157e-01 | 0.011 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.745449e-01 | 0.011 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.745449e-01 | 0.011 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.745449e-01 | 0.011 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.745449e-01 | 0.011 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.754816e-01 | 0.011 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.754816e-01 | 0.011 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.754816e-01 | 0.011 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.762230e-01 | 0.010 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.771704e-01 | 0.010 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.775171e-01 | 0.010 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.786299e-01 | 0.009 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.786299e-01 | 0.009 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.786299e-01 | 0.009 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.786299e-01 | 0.009 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.786299e-01 | 0.009 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.788719e-01 | 0.009 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.788719e-01 | 0.009 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.800361e-01 | 0.009 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.800361e-01 | 0.009 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.811389e-01 | 0.008 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.818057e-01 | 0.008 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.818057e-01 | 0.008 | 0 | 0 |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | R-HSA-2142670 | 9.820595e-01 | 0.008 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.820595e-01 | 0.008 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.820595e-01 | 0.008 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.820595e-01 | 0.008 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.823458e-01 | 0.008 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.824617e-01 | 0.008 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.825547e-01 | 0.008 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.825563e-01 | 0.008 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.832883e-01 | 0.007 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.843422e-01 | 0.007 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.847704e-01 | 0.007 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.847990e-01 | 0.007 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.849389e-01 | 0.007 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 9.849389e-01 | 0.007 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 9.849389e-01 | 0.007 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.849389e-01 | 0.007 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.849389e-01 | 0.007 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.849389e-01 | 0.007 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.850886e-01 | 0.007 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.856360e-01 | 0.006 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.858642e-01 | 0.006 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.861826e-01 | 0.006 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.863641e-01 | 0.006 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.865334e-01 | 0.006 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.867136e-01 | 0.006 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.871247e-01 | 0.006 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.871247e-01 | 0.006 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.871247e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.873562e-01 | 0.006 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.873562e-01 | 0.006 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.879906e-01 | 0.005 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.884173e-01 | 0.005 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.884173e-01 | 0.005 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.884247e-01 | 0.005 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.888762e-01 | 0.005 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.893857e-01 | 0.005 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.893857e-01 | 0.005 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.893857e-01 | 0.005 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.896860e-01 | 0.005 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.900559e-01 | 0.004 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.907056e-01 | 0.004 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.907671e-01 | 0.004 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.910896e-01 | 0.004 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.910896e-01 | 0.004 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.914373e-01 | 0.004 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.914619e-01 | 0.004 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.914619e-01 | 0.004 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.918249e-01 | 0.004 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.918249e-01 | 0.004 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.922902e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.923921e-01 | 0.003 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.925200e-01 | 0.003 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.925200e-01 | 0.003 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.925200e-01 | 0.003 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.925200e-01 | 0.003 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.925200e-01 | 0.003 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.925200e-01 | 0.003 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.925250e-01 | 0.003 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.927666e-01 | 0.003 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.932561e-01 | 0.003 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.937150e-01 | 0.003 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.937208e-01 | 0.003 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.937208e-01 | 0.003 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.937653e-01 | 0.003 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.938490e-01 | 0.003 | 0 | 0 |
| Translation | R-HSA-72766 | 9.940450e-01 | 0.003 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.942266e-01 | 0.003 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.942266e-01 | 0.003 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.944272e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.944583e-01 | 0.002 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.946115e-01 | 0.002 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.946300e-01 | 0.002 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.947290e-01 | 0.002 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.947290e-01 | 0.002 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.947290e-01 | 0.002 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.947290e-01 | 0.002 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.947290e-01 | 0.002 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.950774e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.955661e-01 | 0.002 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.955753e-01 | 0.002 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.955753e-01 | 0.002 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.955753e-01 | 0.002 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.955753e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.955753e-01 | 0.002 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.955753e-01 | 0.002 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.955753e-01 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.958036e-01 | 0.002 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.960444e-01 | 0.002 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.960444e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.960444e-01 | 0.002 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.960444e-01 | 0.002 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.962857e-01 | 0.002 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.962857e-01 | 0.002 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.962857e-01 | 0.002 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.966130e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.968822e-01 | 0.001 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.968822e-01 | 0.001 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.968822e-01 | 0.001 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.968822e-01 | 0.001 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.968822e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.970459e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.971648e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.973028e-01 | 0.001 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.973828e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.974609e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.975824e-01 | 0.001 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.978032e-01 | 0.001 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.978032e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.978032e-01 | 0.001 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.978032e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.978788e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.979459e-01 | 0.001 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.981560e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.984096e-01 | 0.001 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.984500e-01 | 0.001 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.984500e-01 | 0.001 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.984522e-01 | 0.001 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.984522e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.987781e-01 | 0.001 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.988690e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.989741e-01 | 0.000 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.990847e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.991143e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.991143e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.991718e-01 | 0.000 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.992317e-01 | 0.000 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.992317e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.992789e-01 | 0.000 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.993551e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.993551e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.994245e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.994245e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.994315e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.995099e-01 | 0.000 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.995457e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.996105e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.996105e-01 | 0.000 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.996187e-01 | 0.000 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.996187e-01 | 0.000 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.996187e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.996194e-01 | 0.000 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.996800e-01 | 0.000 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.996800e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.997090e-01 | 0.000 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.997314e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.997534e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.997542e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.997705e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.997979e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.997981e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.998004e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.998004e-01 | 0.000 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.998108e-01 | 0.000 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.998108e-01 | 0.000 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.998412e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.998489e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.998625e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.998667e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.998732e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.998897e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.998911e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.998911e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.998911e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.998990e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999057e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999114e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.999126e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999197e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.999310e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.999339e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.999339e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.999445e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999462e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.999534e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.999609e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.999672e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999680e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999694e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999720e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999729e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999729e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999765e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999774e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999828e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999829e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999852e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.999864e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999873e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999876e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999886e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999906e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999911e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.999919e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.999932e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.999943e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999950e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999952e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999960e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999966e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999966e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.999966e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999972e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999972e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999976e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.999980e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999983e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999983e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999986e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999988e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999989e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999990e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999992e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999995e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999996e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999997e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999999e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell-Cell communication | R-HSA-1500931 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.551115e-16 | 15.256 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.994405e-15 | 14.155 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.762857e-14 | 13.322 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.189049e-13 | 12.925 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.373346e-13 | 12.862 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.656453e-13 | 12.781 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.793321e-13 | 12.554 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.793321e-13 | 12.554 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.151923e-13 | 12.501 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.337641e-13 | 12.363 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.209788e-13 | 12.142 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.209788e-13 | 12.142 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.479372e-12 | 11.830 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.679323e-12 | 11.775 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.885381e-12 | 11.725 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.036704e-12 | 11.691 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.609246e-12 | 11.583 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.860645e-12 | 11.232 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.045942e-12 | 11.219 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.180533e-11 | 10.928 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.416667e-11 | 10.617 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.437883e-11 | 10.464 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.744427e-11 | 10.241 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.173984e-11 | 10.037 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.044592e-10 | 9.981 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.242166e-10 | 9.906 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.656527e-10 | 9.781 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.837539e-10 | 9.736 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.987775e-10 | 9.702 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.194404e-10 | 9.659 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.497468e-10 | 9.603 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.837873e-10 | 9.416 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.799437e-10 | 9.420 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.694405e-10 | 9.328 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.456300e-10 | 9.190 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.684303e-10 | 9.014 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.751729e-09 | 8.757 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.932119e-09 | 8.714 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.019836e-09 | 8.695 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.751601e-09 | 8.560 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.191370e-09 | 8.496 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.204055e-09 | 8.494 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.390001e-09 | 8.470 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.390001e-09 | 8.470 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.459244e-09 | 8.461 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.698311e-09 | 8.432 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.344409e-09 | 8.362 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.496788e-09 | 8.347 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.976811e-09 | 8.303 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.526635e-09 | 8.258 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.642591e-09 | 8.117 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.138851e-09 | 8.089 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.135652e-09 | 8.090 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.240988e-09 | 8.084 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.037605e-08 | 7.984 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.201066e-08 | 7.920 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.184603e-08 | 7.926 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.414604e-08 | 7.849 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.948016e-08 | 7.710 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.261321e-08 | 7.646 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.657767e-08 | 7.575 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.705554e-08 | 7.568 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.705554e-08 | 7.568 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.843213e-08 | 7.546 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.874999e-08 | 7.541 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.293280e-08 | 7.482 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.607128e-08 | 7.443 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.810355e-08 | 7.419 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.084045e-08 | 7.389 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.142227e-08 | 7.289 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.747669e-08 | 7.241 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.771699e-08 | 7.109 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.762957e-08 | 7.110 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.950558e-08 | 7.100 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.950558e-08 | 7.100 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.460556e-08 | 7.073 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.460556e-08 | 7.073 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.550164e-08 | 7.068 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 9.291636e-08 | 7.032 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.882953e-08 | 7.005 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.031011e-07 | 6.987 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.109386e-07 | 6.955 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.141035e-07 | 6.943 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.322723e-07 | 6.879 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.951615e-07 | 6.710 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.972074e-07 | 6.705 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.013048e-07 | 6.696 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.491962e-07 | 6.603 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.635707e-07 | 6.579 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.716788e-07 | 6.566 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.718444e-07 | 6.566 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.778096e-07 | 6.556 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.898663e-07 | 6.538 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.121800e-07 | 6.506 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.286130e-07 | 6.483 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.513088e-07 | 6.454 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.768451e-07 | 6.424 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.423093e-07 | 6.354 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.026647e-07 | 6.299 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.037059e-07 | 6.298 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.268846e-07 | 6.278 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.119686e-07 | 6.291 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.687778e-07 | 6.175 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.951500e-07 | 6.158 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.687778e-07 | 6.175 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.788901e-07 | 6.109 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.439813e-07 | 6.074 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 8.456737e-07 | 6.073 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.625918e-07 | 6.064 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.900490e-07 | 6.051 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 9.416676e-07 | 6.026 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.577264e-07 | 6.019 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.536198e-07 | 6.021 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.303950e-06 | 5.885 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.330557e-06 | 5.876 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.404617e-06 | 5.852 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.415470e-06 | 5.849 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.560234e-06 | 5.807 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.839183e-06 | 5.735 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.966412e-06 | 5.706 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.107647e-06 | 5.676 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.560247e-06 | 5.592 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.746068e-06 | 5.561 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.259872e-06 | 5.487 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.445116e-06 | 5.463 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.684134e-06 | 5.434 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.522016e-06 | 5.453 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 3.897942e-06 | 5.409 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.946509e-06 | 5.404 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.140567e-06 | 5.383 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.272119e-06 | 5.369 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.284508e-06 | 5.368 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.706263e-06 | 5.327 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 5.556404e-06 | 5.255 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.831418e-06 | 5.234 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.594140e-06 | 5.252 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.671466e-06 | 5.246 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 6.040344e-06 | 5.219 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.689347e-06 | 5.175 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.714900e-06 | 5.173 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.804197e-06 | 5.167 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.804197e-06 | 5.167 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 6.998119e-06 | 5.155 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.372890e-06 | 5.132 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.372890e-06 | 5.132 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.046599e-06 | 5.094 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.439674e-06 | 5.074 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.839986e-06 | 5.054 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 9.289214e-06 | 5.032 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 9.510059e-06 | 5.022 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.560768e-06 | 5.020 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.962984e-06 | 5.002 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.021196e-05 | 4.991 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.195540e-05 | 4.922 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.203361e-05 | 4.920 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.213979e-05 | 4.916 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.213979e-05 | 4.916 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.223802e-05 | 4.912 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.295027e-05 | 4.888 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.381966e-05 | 4.860 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.488250e-05 | 4.827 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.661383e-05 | 4.780 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.717522e-05 | 4.765 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.953254e-05 | 4.709 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.975187e-05 | 4.704 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.089207e-05 | 4.680 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.225384e-05 | 4.653 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.425654e-05 | 4.615 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.640655e-05 | 4.578 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.640655e-05 | 4.578 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.667031e-05 | 4.574 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.941138e-05 | 4.531 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.992241e-05 | 4.524 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.041466e-05 | 4.517 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.117891e-05 | 4.506 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.145528e-05 | 4.502 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.351391e-05 | 4.475 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.515797e-05 | 4.454 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.230440e-05 | 4.491 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.521033e-05 | 4.453 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.521033e-05 | 4.453 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.521033e-05 | 4.453 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.521033e-05 | 4.453 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.051478e-05 | 4.392 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.236693e-05 | 4.373 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.365406e-05 | 4.360 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.365406e-05 | 4.360 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.514421e-05 | 4.345 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.671608e-05 | 4.331 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.984596e-05 | 4.302 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.047357e-05 | 4.297 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.091642e-05 | 4.293 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 5.351282e-05 | 4.272 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 5.351282e-05 | 4.272 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.273649e-05 | 4.202 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.278183e-05 | 4.138 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.066365e-05 | 4.151 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.755475e-05 | 4.170 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 6.491768e-05 | 4.188 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.607517e-05 | 4.119 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.111233e-05 | 4.091 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.213972e-05 | 4.085 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 9.003743e-05 | 4.046 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.099146e-04 | 3.959 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.252519e-04 | 3.902 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.254973e-04 | 3.901 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.340509e-04 | 3.873 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.381749e-04 | 3.860 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.382191e-04 | 3.859 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.392048e-04 | 3.856 | 0 | 0 |
| Translation | R-HSA-72766 | 1.400776e-04 | 3.854 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.423048e-04 | 3.847 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.423967e-04 | 3.847 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.591916e-04 | 3.798 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.671025e-04 | 3.777 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.761048e-04 | 3.754 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.799788e-04 | 3.745 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.934069e-04 | 3.714 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.252292e-04 | 3.647 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.166375e-04 | 3.664 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.166375e-04 | 3.664 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.430986e-04 | 3.614 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.430986e-04 | 3.614 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.456007e-04 | 3.610 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.456007e-04 | 3.610 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.486015e-04 | 3.604 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.720990e-04 | 3.565 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.767439e-04 | 3.558 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.977484e-04 | 3.526 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.052063e-04 | 3.515 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.068090e-04 | 3.513 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 3.089482e-04 | 3.510 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.306782e-04 | 3.481 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.308833e-04 | 3.480 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.791369e-04 | 3.421 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.842482e-04 | 3.415 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.842482e-04 | 3.415 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.010415e-04 | 3.397 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.254192e-04 | 3.371 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.396549e-04 | 3.357 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.602430e-04 | 3.337 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.646093e-04 | 3.333 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.667520e-04 | 3.331 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.843649e-04 | 3.315 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.109666e-04 | 3.292 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.200166e-04 | 3.284 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.333637e-04 | 3.198 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.333637e-04 | 3.198 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 6.274992e-04 | 3.202 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.581644e-04 | 3.182 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.581644e-04 | 3.182 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.280507e-04 | 3.202 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 5.763495e-04 | 3.239 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.495154e-04 | 3.187 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.650636e-04 | 3.177 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.672115e-04 | 3.176 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.776238e-04 | 3.169 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.811976e-04 | 3.167 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 7.053558e-04 | 3.152 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.273904e-04 | 3.138 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.273904e-04 | 3.138 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.638376e-04 | 3.117 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.638376e-04 | 3.117 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.768830e-04 | 3.110 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.768830e-04 | 3.110 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.768830e-04 | 3.110 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.828971e-04 | 3.106 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.047276e-04 | 3.094 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.091392e-04 | 3.092 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.110902e-04 | 3.091 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.162528e-04 | 3.088 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.170693e-04 | 3.088 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.331302e-04 | 3.079 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.446200e-04 | 3.073 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.758327e-04 | 3.058 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.927275e-04 | 3.049 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.955417e-04 | 3.048 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 9.256007e-04 | 3.034 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 9.256007e-04 | 3.034 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.563790e-04 | 3.019 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.838671e-04 | 3.007 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.028815e-03 | 2.988 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.044348e-03 | 2.981 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.044348e-03 | 2.981 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.063416e-03 | 2.973 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.129612e-03 | 2.947 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.178651e-03 | 2.929 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.063416e-03 | 2.973 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.207287e-03 | 2.918 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.155639e-03 | 2.937 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.182710e-03 | 2.927 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.275659e-03 | 2.894 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.233546e-03 | 2.909 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.327922e-03 | 2.877 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.327922e-03 | 2.877 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.350018e-03 | 2.870 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.405291e-03 | 2.852 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.451784e-03 | 2.838 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.509247e-03 | 2.821 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.549592e-03 | 2.810 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.640430e-03 | 2.785 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.640430e-03 | 2.785 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.640430e-03 | 2.785 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.645284e-03 | 2.784 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.645284e-03 | 2.784 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.724834e-03 | 2.763 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.724834e-03 | 2.763 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.818800e-03 | 2.740 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.818800e-03 | 2.740 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.823013e-03 | 2.739 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.823013e-03 | 2.739 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.893142e-03 | 2.723 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.970582e-03 | 2.705 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.996130e-03 | 2.700 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.996483e-03 | 2.700 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.023331e-03 | 2.694 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.030939e-03 | 2.692 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.060187e-03 | 2.686 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.060187e-03 | 2.686 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.166588e-03 | 2.664 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 2.277474e-03 | 2.643 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.298643e-03 | 2.639 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.308904e-03 | 2.637 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.315210e-03 | 2.635 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.318289e-03 | 2.635 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.399639e-03 | 2.620 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.401067e-03 | 2.620 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.441734e-03 | 2.612 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.458255e-03 | 2.609 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.472496e-03 | 2.607 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.479292e-03 | 2.606 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.587545e-03 | 2.587 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.587545e-03 | 2.587 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.587545e-03 | 2.587 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.614697e-03 | 2.583 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.630804e-03 | 2.580 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.831879e-03 | 2.548 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.840137e-03 | 2.547 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.554703e-03 | 2.449 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.554703e-03 | 2.449 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.554703e-03 | 2.449 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.996248e-03 | 2.523 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.310272e-03 | 2.480 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.311939e-03 | 2.480 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 3.554814e-03 | 2.449 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.996248e-03 | 2.523 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.310272e-03 | 2.480 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.996248e-03 | 2.523 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.996248e-03 | 2.523 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.987540e-03 | 2.525 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.496696e-03 | 2.456 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.554703e-03 | 2.449 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.554703e-03 | 2.449 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.952505e-03 | 2.530 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.596442e-03 | 2.444 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.596442e-03 | 2.444 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.603058e-03 | 2.443 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.610200e-03 | 2.442 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.610200e-03 | 2.442 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.610200e-03 | 2.442 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.827389e-03 | 2.417 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.003071e-03 | 2.398 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.064679e-03 | 2.391 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.216287e-03 | 2.375 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.264449e-03 | 2.370 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.322968e-03 | 2.364 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 4.322968e-03 | 2.364 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.345977e-03 | 2.362 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.365211e-03 | 2.360 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.520049e-03 | 2.345 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.760816e-03 | 2.322 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.888487e-03 | 2.311 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.997106e-03 | 2.301 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.252193e-03 | 2.280 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.252193e-03 | 2.280 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.252193e-03 | 2.280 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.266023e-03 | 2.279 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.266023e-03 | 2.279 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.796945e-03 | 2.237 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.103185e-03 | 2.214 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 6.103185e-03 | 2.214 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 6.103185e-03 | 2.214 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.149522e-03 | 2.211 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.277921e-03 | 2.202 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.332165e-03 | 2.198 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 6.372422e-03 | 2.196 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.505779e-03 | 2.187 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.832470e-03 | 2.165 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.859168e-03 | 2.164 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.981526e-03 | 2.156 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.115945e-03 | 2.148 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.160602e-03 | 2.145 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.168484e-03 | 2.145 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.169527e-03 | 2.145 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.169527e-03 | 2.145 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.246765e-03 | 2.140 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 7.850262e-03 | 2.105 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 9.328396e-03 | 2.030 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.716011e-03 | 2.113 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 7.654756e-03 | 2.116 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.654756e-03 | 2.116 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 9.131061e-03 | 2.039 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.393527e-03 | 2.076 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.393527e-03 | 2.076 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.872093e-03 | 2.104 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.007339e-03 | 2.045 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 9.839169e-03 | 2.007 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 8.804277e-03 | 2.055 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 7.836128e-03 | 2.106 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.482595e-03 | 2.126 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 7.760654e-03 | 2.110 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.719705e-03 | 2.112 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 9.839169e-03 | 2.007 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 9.197807e-03 | 2.036 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.870929e-03 | 2.052 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.778385e-03 | 2.010 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 9.131061e-03 | 2.039 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.609573e-03 | 2.065 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.609573e-03 | 2.065 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.609573e-03 | 2.065 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.778385e-03 | 2.010 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.934038e-03 | 2.101 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.934038e-03 | 2.101 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 8.222228e-03 | 2.085 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.748914e-03 | 2.111 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.541581e-03 | 2.068 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.868782e-03 | 2.006 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 9.940245e-03 | 2.003 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 9.940245e-03 | 2.003 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 9.940245e-03 | 2.003 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.006481e-02 | 1.997 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.024730e-02 | 1.989 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.051497e-02 | 1.978 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 1.053466e-02 | 1.977 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.058616e-02 | 1.975 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.058616e-02 | 1.975 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.097974e-02 | 1.959 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.110855e-02 | 1.954 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.117950e-02 | 1.952 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.119356e-02 | 1.951 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.119356e-02 | 1.951 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.133653e-02 | 1.946 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.133967e-02 | 1.945 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.176153e-02 | 1.930 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.206638e-02 | 1.918 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.215060e-02 | 1.915 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.215060e-02 | 1.915 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.215060e-02 | 1.915 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.223575e-02 | 1.912 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.223575e-02 | 1.912 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.273997e-02 | 1.895 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.273997e-02 | 1.895 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.278512e-02 | 1.893 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.317210e-02 | 1.880 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.330429e-02 | 1.876 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.335461e-02 | 1.874 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.335461e-02 | 1.874 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.335461e-02 | 1.874 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.366871e-02 | 1.864 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.368099e-02 | 1.864 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.370668e-02 | 1.863 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.370668e-02 | 1.863 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.370668e-02 | 1.863 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.370668e-02 | 1.863 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.388992e-02 | 1.857 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.388992e-02 | 1.857 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.392591e-02 | 1.856 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.401307e-02 | 1.853 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.444912e-02 | 1.840 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.451641e-02 | 1.838 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.451641e-02 | 1.838 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.498547e-02 | 1.824 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.523732e-02 | 1.817 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.523732e-02 | 1.817 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.523732e-02 | 1.817 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.523732e-02 | 1.817 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.523732e-02 | 1.817 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.523732e-02 | 1.817 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.523732e-02 | 1.817 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.523732e-02 | 1.817 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.523732e-02 | 1.817 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.523732e-02 | 1.817 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.523732e-02 | 1.817 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.524157e-02 | 1.817 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.531924e-02 | 1.815 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.542510e-02 | 1.812 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.574500e-02 | 1.803 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.619172e-02 | 1.791 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.631528e-02 | 1.787 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.636662e-02 | 1.786 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.636662e-02 | 1.786 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.638272e-02 | 1.786 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.640961e-02 | 1.785 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.661130e-02 | 1.780 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.712135e-02 | 1.766 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.718877e-02 | 1.765 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.818008e-02 | 1.740 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.818008e-02 | 1.740 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.818008e-02 | 1.740 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.818008e-02 | 1.740 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.845379e-02 | 1.734 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.845379e-02 | 1.734 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.845379e-02 | 1.734 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.848780e-02 | 1.733 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.848780e-02 | 1.733 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.861853e-02 | 1.730 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.942400e-02 | 1.712 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.942400e-02 | 1.712 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.942400e-02 | 1.712 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.942400e-02 | 1.712 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.007847e-02 | 1.697 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.007847e-02 | 1.697 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.015760e-02 | 1.696 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.015760e-02 | 1.696 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.015760e-02 | 1.696 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.015760e-02 | 1.696 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.027168e-02 | 1.693 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.027889e-02 | 1.693 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.759021e-02 | 1.559 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.759021e-02 | 1.559 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.759021e-02 | 1.559 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.759021e-02 | 1.559 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.759021e-02 | 1.559 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.759021e-02 | 1.559 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.759021e-02 | 1.559 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.712151e-02 | 1.567 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.712151e-02 | 1.567 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.957024e-02 | 1.529 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.957024e-02 | 1.529 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.716949e-02 | 1.566 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 2.716949e-02 | 1.566 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.356172e-02 | 1.628 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.991822e-02 | 1.524 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.479810e-02 | 1.606 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.040425e-02 | 1.690 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.040425e-02 | 1.690 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.477443e-02 | 1.606 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.842467e-02 | 1.546 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.287980e-02 | 1.641 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.287980e-02 | 1.641 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.495214e-02 | 1.603 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.017565e-02 | 1.520 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.754687e-02 | 1.560 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.287980e-02 | 1.641 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.311347e-02 | 1.636 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.495214e-02 | 1.603 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.311347e-02 | 1.636 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.036214e-02 | 1.691 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.991822e-02 | 1.524 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.311347e-02 | 1.636 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.737476e-02 | 1.563 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.044452e-02 | 1.516 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.152345e-02 | 1.667 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.287980e-02 | 1.641 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.884129e-02 | 1.540 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.884129e-02 | 1.540 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.991822e-02 | 1.524 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.934102e-02 | 1.533 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.036214e-02 | 1.691 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.044452e-02 | 1.516 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.287980e-02 | 1.641 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.209055e-02 | 1.656 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.477443e-02 | 1.606 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.036214e-02 | 1.691 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.428052e-02 | 1.615 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.605526e-02 | 1.584 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.402821e-02 | 1.619 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.495214e-02 | 1.603 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.561234e-02 | 1.592 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.959628e-02 | 1.529 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.495214e-02 | 1.603 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.985472e-02 | 1.525 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.152108e-02 | 1.667 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.716949e-02 | 1.566 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.825862e-02 | 1.549 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.105133e-02 | 1.677 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.152108e-02 | 1.667 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.510006e-02 | 1.600 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.106347e-02 | 1.676 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.886139e-02 | 1.540 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.356172e-02 | 1.628 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.130953e-02 | 1.671 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.479810e-02 | 1.606 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 2.036214e-02 | 1.691 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 2.036214e-02 | 1.691 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.108767e-02 | 1.507 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.108767e-02 | 1.507 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.108767e-02 | 1.507 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.127544e-02 | 1.505 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 3.159834e-02 | 1.500 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.198069e-02 | 1.495 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.335638e-02 | 1.477 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.335638e-02 | 1.477 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 3.351612e-02 | 1.475 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.470039e-02 | 1.460 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.502448e-02 | 1.456 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.555202e-02 | 1.449 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.556463e-02 | 1.449 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.556463e-02 | 1.449 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.588650e-02 | 1.445 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.588650e-02 | 1.445 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.689593e-02 | 1.433 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.730455e-02 | 1.428 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.730455e-02 | 1.428 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.730455e-02 | 1.428 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.730455e-02 | 1.428 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.730455e-02 | 1.428 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 3.730455e-02 | 1.428 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.730455e-02 | 1.428 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 3.730455e-02 | 1.428 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.730455e-02 | 1.428 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.759520e-02 | 1.425 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.802079e-02 | 1.420 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.802079e-02 | 1.420 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 3.867247e-02 | 1.413 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.872383e-02 | 1.412 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.884919e-02 | 1.411 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.884919e-02 | 1.411 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.947867e-02 | 1.404 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 4.088198e-02 | 1.388 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.088198e-02 | 1.388 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.117668e-02 | 1.385 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.170826e-02 | 1.380 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.170826e-02 | 1.380 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.170826e-02 | 1.380 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.241395e-02 | 1.372 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.273902e-02 | 1.369 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.349709e-02 | 1.362 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.349709e-02 | 1.362 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.349709e-02 | 1.362 | 0 | 0 |
| Immune System | R-HSA-168256 | 4.378225e-02 | 1.359 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.539757e-02 | 1.343 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 4.576307e-02 | 1.339 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.576307e-02 | 1.339 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.628079e-02 | 1.335 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 4.662868e-02 | 1.331 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.697656e-02 | 1.328 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.798474e-02 | 1.319 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.105110e-02 | 1.292 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.113341e-02 | 1.291 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.160606e-02 | 1.287 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.210671e-02 | 1.283 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.234635e-02 | 1.281 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 5.234635e-02 | 1.281 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.432252e-02 | 1.265 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.432252e-02 | 1.265 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.432252e-02 | 1.265 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 5.432252e-02 | 1.265 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.432252e-02 | 1.265 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.532282e-02 | 1.257 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.532282e-02 | 1.257 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.532282e-02 | 1.257 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.532282e-02 | 1.257 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.532282e-02 | 1.257 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.545290e-02 | 1.256 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.634757e-02 | 1.249 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.646917e-02 | 1.248 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.669737e-02 | 1.246 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.685390e-02 | 1.245 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 5.714402e-02 | 1.243 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 5.714402e-02 | 1.243 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 5.714402e-02 | 1.243 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.773373e-02 | 1.239 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.890554e-02 | 1.230 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 5.890554e-02 | 1.230 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.016657e-02 | 1.221 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 6.059572e-02 | 1.218 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.139206e-02 | 1.212 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.139206e-02 | 1.212 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.139206e-02 | 1.212 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.157921e-02 | 1.211 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 6.193399e-02 | 1.208 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.193399e-02 | 1.208 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.193399e-02 | 1.208 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.242874e-02 | 1.205 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.242874e-02 | 1.205 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.242874e-02 | 1.205 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 6.275155e-02 | 1.202 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.291987e-02 | 1.201 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.318182e-02 | 1.199 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.334338e-02 | 1.198 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.394290e-02 | 1.194 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.394290e-02 | 1.194 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.394290e-02 | 1.194 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 6.495096e-02 | 1.187 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.495096e-02 | 1.187 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.592795e-02 | 1.181 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.683647e-02 | 1.175 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.683647e-02 | 1.175 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.683647e-02 | 1.175 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.683647e-02 | 1.175 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.695351e-02 | 1.174 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.753199e-02 | 1.170 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.937979e-02 | 1.159 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.946828e-02 | 1.158 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.946828e-02 | 1.158 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.986282e-02 | 1.156 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 6.986282e-02 | 1.156 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.986282e-02 | 1.156 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.073689e-02 | 1.150 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.133554e-02 | 1.147 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.263431e-02 | 1.139 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.263431e-02 | 1.139 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.496038e-02 | 1.125 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.544867e-02 | 1.122 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.544867e-02 | 1.122 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.555156e-02 | 1.122 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.779472e-02 | 1.109 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.779472e-02 | 1.109 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 7.779472e-02 | 1.109 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 7.779472e-02 | 1.109 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.820359e-02 | 1.107 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 8.040733e-02 | 1.095 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 8.217945e-02 | 1.085 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.217945e-02 | 1.085 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.288582e-02 | 1.082 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.288582e-02 | 1.082 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.369111e-02 | 1.077 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.369111e-02 | 1.077 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.369111e-02 | 1.077 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.369111e-02 | 1.077 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.416276e-02 | 1.075 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.416276e-02 | 1.075 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.416276e-02 | 1.075 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.442519e-02 | 1.074 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 8.442519e-02 | 1.074 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 8.442519e-02 | 1.074 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 8.442519e-02 | 1.074 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.462143e-02 | 1.073 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 8.462143e-02 | 1.073 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.462143e-02 | 1.073 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.531190e-02 | 1.069 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.660887e-02 | 1.062 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.199761e-01 | 0.921 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.199761e-01 | 0.921 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.199761e-01 | 0.921 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.199761e-01 | 0.921 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.199761e-01 | 0.921 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.199761e-01 | 0.921 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.199761e-01 | 0.921 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.199761e-01 | 0.921 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.199761e-01 | 0.921 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.199761e-01 | 0.921 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.199761e-01 | 0.921 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.199761e-01 | 0.921 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.199761e-01 | 0.921 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.199761e-01 | 0.921 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.199761e-01 | 0.921 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.199761e-01 | 0.921 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.199761e-01 | 0.921 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 9.360356e-02 | 1.029 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.348880e-01 | 0.870 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.348880e-01 | 0.870 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.348880e-01 | 0.870 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.098513e-01 | 0.959 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 1.098513e-01 | 0.959 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 8.742705e-02 | 1.058 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.742705e-02 | 1.058 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.378057e-01 | 0.861 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 1.378057e-01 | 0.861 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.378057e-01 | 0.861 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.678625e-01 | 0.775 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.678625e-01 | 0.775 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.678625e-01 | 0.775 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.678625e-01 | 0.775 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.281374e-01 | 0.892 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.281374e-01 | 0.892 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.069804e-02 | 1.042 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.163106e-01 | 0.934 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.163106e-01 | 0.934 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.509689e-01 | 0.821 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.509689e-01 | 0.821 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.509689e-01 | 0.821 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.509689e-01 | 0.821 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.509689e-01 | 0.821 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.509689e-01 | 0.821 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.509689e-01 | 0.821 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.509689e-01 | 0.821 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.509689e-01 | 0.821 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.345710e-01 | 0.871 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.345710e-01 | 0.871 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 9.391822e-02 | 1.027 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.197240e-01 | 0.922 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.357667e-01 | 0.867 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.200185e-01 | 0.921 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 1.745428e-01 | 0.758 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 1.527598e-01 | 0.816 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.343306e-01 | 0.872 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.343306e-01 | 0.872 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.494396e-01 | 0.826 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.494396e-01 | 0.826 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.131088e-02 | 1.039 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 9.131088e-02 | 1.039 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.248712e-01 | 0.904 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 9.718898e-02 | 1.012 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.318038e-02 | 1.031 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 1.745428e-01 | 0.758 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.278585e-01 | 0.893 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.540156e-01 | 0.812 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.562982e-01 | 0.806 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.333337e-01 | 0.875 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.745428e-01 | 0.758 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.063674e-01 | 0.973 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.281374e-01 | 0.892 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.678625e-01 | 0.775 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 1.678625e-01 | 0.775 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.281374e-01 | 0.892 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 8.742705e-02 | 1.058 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.020012e-01 | 0.991 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.676009e-01 | 0.776 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.676009e-01 | 0.776 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.676009e-01 | 0.776 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.676009e-01 | 0.776 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.509689e-01 | 0.821 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.450822e-01 | 0.838 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.150027e-01 | 0.939 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.046860e-01 | 0.980 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.096583e-01 | 0.960 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.049779e-01 | 0.979 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.678625e-01 | 0.775 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 1.678625e-01 | 0.775 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 1.678625e-01 | 0.775 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.540156e-01 | 0.812 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.130534e-01 | 0.947 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.268323e-01 | 0.897 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.619915e-01 | 0.791 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.540156e-01 | 0.812 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.523322e-01 | 0.817 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.527598e-01 | 0.816 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.653049e-01 | 0.782 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.703551e-01 | 0.769 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.069804e-02 | 1.042 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.378057e-01 | 0.861 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 9.155357e-02 | 1.038 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.666578e-01 | 0.778 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.676009e-01 | 0.776 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.057530e-01 | 0.976 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 1.322710e-01 | 0.879 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.745428e-01 | 0.758 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.523372e-01 | 0.817 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.002358e-01 | 0.999 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.531541e-01 | 0.815 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.671459e-01 | 0.777 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.046860e-01 | 0.980 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 1.745428e-01 | 0.758 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.109450e-01 | 0.955 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.343306e-01 | 0.872 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.590260e-01 | 0.799 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.666578e-01 | 0.778 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.357667e-01 | 0.867 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.314821e-01 | 0.881 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.357667e-01 | 0.867 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.378057e-01 | 0.861 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.678625e-01 | 0.775 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 1.509689e-01 | 0.821 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.598231e-01 | 0.796 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.666517e-01 | 0.778 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.152554e-01 | 0.938 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 9.932519e-02 | 1.003 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.261661e-01 | 0.899 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.163106e-01 | 0.934 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.389107e-01 | 0.857 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 1.450822e-01 | 0.838 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.357667e-01 | 0.867 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.155357e-02 | 1.038 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.509689e-01 | 0.821 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.509689e-01 | 0.821 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.509689e-01 | 0.821 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.318038e-02 | 1.031 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.197240e-01 | 0.922 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.083234e-01 | 0.965 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.742705e-02 | 1.058 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.509689e-01 | 0.821 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.745428e-01 | 0.758 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.752093e-01 | 0.756 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.752093e-01 | 0.756 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.752093e-01 | 0.756 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.752093e-01 | 0.756 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.792965e-01 | 0.746 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.793159e-01 | 0.746 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.793159e-01 | 0.746 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.793159e-01 | 0.746 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.793159e-01 | 0.746 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.793159e-01 | 0.746 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.793159e-01 | 0.746 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 1.793159e-01 | 0.746 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.793159e-01 | 0.746 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.806992e-01 | 0.743 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 1.818803e-01 | 0.740 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.818803e-01 | 0.740 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.893405e-01 | 0.723 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 1.893405e-01 | 0.723 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.917311e-01 | 0.717 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.920347e-01 | 0.717 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 1.952500e-01 | 0.709 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.960420e-01 | 0.708 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.960420e-01 | 0.708 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.991770e-01 | 0.701 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.995963e-01 | 0.700 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.995963e-01 | 0.700 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.995963e-01 | 0.700 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.995963e-01 | 0.700 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 1.995963e-01 | 0.700 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.006630e-01 | 0.698 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.006630e-01 | 0.698 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.019304e-01 | 0.695 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 2.019304e-01 | 0.695 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.043027e-01 | 0.690 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.087840e-01 | 0.680 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.169554e-01 | 0.664 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.169554e-01 | 0.664 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.183964e-01 | 0.661 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.183964e-01 | 0.661 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.183964e-01 | 0.661 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.255398e-01 | 0.647 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.255398e-01 | 0.647 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.255398e-01 | 0.647 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 2.255398e-01 | 0.647 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.255398e-01 | 0.647 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.255398e-01 | 0.647 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.255398e-01 | 0.647 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.255398e-01 | 0.647 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.255398e-01 | 0.647 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 2.255398e-01 | 0.647 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.255398e-01 | 0.647 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.255641e-01 | 0.647 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.255641e-01 | 0.647 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.255641e-01 | 0.647 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 2.255641e-01 | 0.647 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 2.255641e-01 | 0.647 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.255641e-01 | 0.647 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 2.255641e-01 | 0.647 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 2.255641e-01 | 0.647 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 2.255641e-01 | 0.647 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.255641e-01 | 0.647 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.257543e-01 | 0.646 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.257543e-01 | 0.646 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.271297e-01 | 0.644 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 2.271297e-01 | 0.644 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.277394e-01 | 0.643 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.288926e-01 | 0.640 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.297490e-01 | 0.639 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.325955e-01 | 0.633 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.325955e-01 | 0.633 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.325955e-01 | 0.633 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.325955e-01 | 0.633 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 2.325955e-01 | 0.633 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.325955e-01 | 0.633 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.353431e-01 | 0.628 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.353431e-01 | 0.628 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.353431e-01 | 0.628 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.353431e-01 | 0.628 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.393069e-01 | 0.621 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.403915e-01 | 0.619 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.413719e-01 | 0.617 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.414855e-01 | 0.617 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 2.414855e-01 | 0.617 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.414855e-01 | 0.617 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.414855e-01 | 0.617 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.428525e-01 | 0.615 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.495841e-01 | 0.603 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.495841e-01 | 0.603 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.524718e-01 | 0.598 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.544091e-01 | 0.594 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.544091e-01 | 0.594 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.544091e-01 | 0.594 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.544091e-01 | 0.594 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.544091e-01 | 0.594 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.544091e-01 | 0.594 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.552250e-01 | 0.593 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.555521e-01 | 0.593 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.567438e-01 | 0.591 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.567438e-01 | 0.591 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.567438e-01 | 0.591 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 2.574073e-01 | 0.589 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.578998e-01 | 0.589 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.622204e-01 | 0.581 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.651868e-01 | 0.576 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.664726e-01 | 0.574 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.664726e-01 | 0.574 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.664726e-01 | 0.574 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.664726e-01 | 0.574 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.664726e-01 | 0.574 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 2.664726e-01 | 0.574 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.707748e-01 | 0.567 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.707748e-01 | 0.567 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 2.724082e-01 | 0.565 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 2.724897e-01 | 0.565 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.724897e-01 | 0.565 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.724897e-01 | 0.565 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.724897e-01 | 0.565 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.724897e-01 | 0.565 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.724897e-01 | 0.565 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.724897e-01 | 0.565 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.724897e-01 | 0.565 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.724897e-01 | 0.565 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.724897e-01 | 0.565 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.735201e-01 | 0.563 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.735201e-01 | 0.563 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 2.796841e-01 | 0.553 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.823046e-01 | 0.549 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.823046e-01 | 0.549 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.823046e-01 | 0.549 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.823046e-01 | 0.549 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 2.823046e-01 | 0.549 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.849548e-01 | 0.545 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.874884e-01 | 0.541 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.913901e-01 | 0.536 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.913901e-01 | 0.536 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.923801e-01 | 0.534 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.923801e-01 | 0.534 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 2.923801e-01 | 0.534 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.008698e-01 | 0.522 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 3.008698e-01 | 0.522 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 3.008698e-01 | 0.522 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.008698e-01 | 0.522 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.008698e-01 | 0.522 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.056556e-01 | 0.515 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.056816e-01 | 0.515 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.056816e-01 | 0.515 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.100223e-01 | 0.509 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.106268e-01 | 0.508 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.106268e-01 | 0.508 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.106268e-01 | 0.508 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.106268e-01 | 0.508 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.106268e-01 | 0.508 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 3.106268e-01 | 0.508 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.139395e-01 | 0.503 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.139395e-01 | 0.503 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.143155e-01 | 0.503 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.184888e-01 | 0.497 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 3.184888e-01 | 0.497 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.184888e-01 | 0.497 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.184888e-01 | 0.497 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 3.184888e-01 | 0.497 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.184888e-01 | 0.497 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.184888e-01 | 0.497 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.184888e-01 | 0.497 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.184888e-01 | 0.497 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 3.184888e-01 | 0.497 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.184888e-01 | 0.497 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 3.184888e-01 | 0.497 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.184888e-01 | 0.497 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.193265e-01 | 0.496 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.193265e-01 | 0.496 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.193265e-01 | 0.496 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.193265e-01 | 0.496 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.193265e-01 | 0.496 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.193265e-01 | 0.496 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.193265e-01 | 0.496 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.193265e-01 | 0.496 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.193265e-01 | 0.496 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.213217e-01 | 0.493 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.219619e-01 | 0.492 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.287612e-01 | 0.483 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.290691e-01 | 0.483 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.297517e-01 | 0.482 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.297517e-01 | 0.482 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.297517e-01 | 0.482 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.347143e-01 | 0.475 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 3.354635e-01 | 0.474 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.354635e-01 | 0.474 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.354635e-01 | 0.474 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.354635e-01 | 0.474 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 3.354635e-01 | 0.474 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.364976e-01 | 0.473 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.364976e-01 | 0.473 | 0 | 0 |
| PKA activation | R-HSA-163615 | 3.391959e-01 | 0.470 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.391959e-01 | 0.470 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 3.391959e-01 | 0.470 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.446443e-01 | 0.463 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 3.503045e-01 | 0.456 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.537328e-01 | 0.451 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.537328e-01 | 0.451 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.587340e-01 | 0.445 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.637070e-01 | 0.439 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.654019e-01 | 0.437 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 3.654019e-01 | 0.437 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.654019e-01 | 0.437 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.654019e-01 | 0.437 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.654019e-01 | 0.437 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.654019e-01 | 0.437 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.654019e-01 | 0.437 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.654019e-01 | 0.437 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 3.654019e-01 | 0.437 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.654019e-01 | 0.437 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.654019e-01 | 0.437 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.654019e-01 | 0.437 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.654019e-01 | 0.437 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.654019e-01 | 0.437 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.675263e-01 | 0.435 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.675263e-01 | 0.435 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 3.678434e-01 | 0.434 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.678434e-01 | 0.434 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.678434e-01 | 0.434 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.678434e-01 | 0.434 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 3.678434e-01 | 0.434 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.678434e-01 | 0.434 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.678434e-01 | 0.434 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 3.696339e-01 | 0.432 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.699652e-01 | 0.432 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 3.699652e-01 | 0.432 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.699652e-01 | 0.432 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.723431e-01 | 0.429 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 3.742266e-01 | 0.427 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.742266e-01 | 0.427 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.812791e-01 | 0.419 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.865616e-01 | 0.413 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.886937e-01 | 0.410 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 3.959500e-01 | 0.402 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 3.964134e-01 | 0.402 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.964134e-01 | 0.402 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 3.964134e-01 | 0.402 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 3.964134e-01 | 0.402 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.964134e-01 | 0.402 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.964134e-01 | 0.402 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.964134e-01 | 0.402 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.964134e-01 | 0.402 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.964134e-01 | 0.402 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.965760e-01 | 0.402 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.002681e-01 | 0.398 | 0 | 0 |
| Defective PAPSS2 causes SEMD-PA | R-HSA-3560796 | 4.002681e-01 | 0.398 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.002681e-01 | 0.398 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 4.002681e-01 | 0.398 | 0 | 0 |
| Defective ABCB6 causes MCOPCB7 | R-HSA-5683371 | 4.002681e-01 | 0.398 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 4.002681e-01 | 0.398 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.002681e-01 | 0.398 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.002681e-01 | 0.398 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 4.002681e-01 | 0.398 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 4.002681e-01 | 0.398 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.002681e-01 | 0.398 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.002681e-01 | 0.398 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 4.002681e-01 | 0.398 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.041226e-01 | 0.393 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 4.041226e-01 | 0.393 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.042310e-01 | 0.393 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.054826e-01 | 0.392 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.056331e-01 | 0.392 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.056331e-01 | 0.392 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.102244e-01 | 0.387 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.102244e-01 | 0.387 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 4.102244e-01 | 0.387 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.102244e-01 | 0.387 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.102244e-01 | 0.387 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 4.102244e-01 | 0.387 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.102244e-01 | 0.387 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.102244e-01 | 0.387 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.136124e-01 | 0.383 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.136124e-01 | 0.383 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 4.136124e-01 | 0.383 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.153239e-01 | 0.382 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.246958e-01 | 0.372 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 4.247638e-01 | 0.372 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.247638e-01 | 0.372 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 4.247638e-01 | 0.372 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 4.261073e-01 | 0.370 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 4.261073e-01 | 0.370 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.261073e-01 | 0.370 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.261073e-01 | 0.370 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.357577e-01 | 0.361 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.377183e-01 | 0.359 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.377183e-01 | 0.359 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.377183e-01 | 0.359 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.383691e-01 | 0.358 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.383691e-01 | 0.358 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 4.383691e-01 | 0.358 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.383691e-01 | 0.358 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.383691e-01 | 0.358 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.437062e-01 | 0.353 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.483616e-01 | 0.348 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 4.483616e-01 | 0.348 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.527664e-01 | 0.344 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.527664e-01 | 0.344 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.534315e-01 | 0.343 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 4.534315e-01 | 0.343 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.534315e-01 | 0.343 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.534315e-01 | 0.343 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.534315e-01 | 0.343 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.534315e-01 | 0.343 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.534315e-01 | 0.343 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.534315e-01 | 0.343 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.534315e-01 | 0.343 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.561990e-01 | 0.341 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 4.628771e-01 | 0.335 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.629054e-01 | 0.335 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.684501e-01 | 0.329 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.690158e-01 | 0.329 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.704230e-01 | 0.328 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 4.705684e-01 | 0.327 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 4.705684e-01 | 0.327 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 4.705684e-01 | 0.327 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.722384e-01 | 0.326 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.722384e-01 | 0.326 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.722384e-01 | 0.326 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.722384e-01 | 0.326 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.722384e-01 | 0.326 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.722384e-01 | 0.326 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 4.722384e-01 | 0.326 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.722384e-01 | 0.326 | 0 | 0 |
| Activation of BMF and translocation to mitochondria | R-HSA-139910 | 4.722384e-01 | 0.326 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.722384e-01 | 0.326 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.722384e-01 | 0.326 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.803073e-01 | 0.318 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.803073e-01 | 0.318 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 4.803073e-01 | 0.318 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.803073e-01 | 0.318 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.947656e-01 | 0.306 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.947656e-01 | 0.306 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.947656e-01 | 0.306 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 4.947656e-01 | 0.306 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.947656e-01 | 0.306 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 4.957142e-01 | 0.305 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 4.963814e-01 | 0.304 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.000194e-01 | 0.301 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 5.025203e-01 | 0.299 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.025203e-01 | 0.299 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.025203e-01 | 0.299 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 5.031325e-01 | 0.298 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.059023e-01 | 0.296 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.072865e-01 | 0.295 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.072865e-01 | 0.295 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.075517e-01 | 0.295 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.137363e-01 | 0.289 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.137363e-01 | 0.289 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.162234e-01 | 0.287 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.166363e-01 | 0.287 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.334506e-01 | 0.273 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.334506e-01 | 0.273 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 5.336178e-01 | 0.273 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 5.336178e-01 | 0.273 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.340541e-01 | 0.272 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.340541e-01 | 0.272 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.340541e-01 | 0.272 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.340541e-01 | 0.272 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.340541e-01 | 0.272 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 5.340541e-01 | 0.272 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.340541e-01 | 0.272 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.340541e-01 | 0.272 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.341566e-01 | 0.272 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.348846e-01 | 0.272 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.355756e-01 | 0.271 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.355756e-01 | 0.271 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.355756e-01 | 0.271 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.355756e-01 | 0.271 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.355756e-01 | 0.271 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.355756e-01 | 0.271 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.355756e-01 | 0.271 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.355756e-01 | 0.271 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.355756e-01 | 0.271 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.355756e-01 | 0.271 | 0 | 0 |
| Interleukin-38 signaling | R-HSA-9007892 | 5.355756e-01 | 0.271 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.375058e-01 | 0.270 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.544963e-01 | 0.256 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.556331e-01 | 0.255 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.556331e-01 | 0.255 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 5.556331e-01 | 0.255 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 5.592281e-01 | 0.252 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 5.592281e-01 | 0.252 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 5.592281e-01 | 0.252 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 5.592281e-01 | 0.252 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.592281e-01 | 0.252 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.592281e-01 | 0.252 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 5.599840e-01 | 0.252 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.632622e-01 | 0.249 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.709642e-01 | 0.243 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 5.711927e-01 | 0.243 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.711927e-01 | 0.243 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.711927e-01 | 0.243 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.711927e-01 | 0.243 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.711927e-01 | 0.243 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 5.711927e-01 | 0.243 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 5.720040e-01 | 0.243 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.791869e-01 | 0.237 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.840567e-01 | 0.234 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 5.840567e-01 | 0.234 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.840567e-01 | 0.234 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 5.840567e-01 | 0.234 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.844092e-01 | 0.233 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.913149e-01 | 0.228 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.913149e-01 | 0.228 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.913149e-01 | 0.228 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.913149e-01 | 0.228 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 5.913149e-01 | 0.228 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.913149e-01 | 0.228 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.913149e-01 | 0.228 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.913149e-01 | 0.228 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.913149e-01 | 0.228 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 5.913149e-01 | 0.228 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.913149e-01 | 0.228 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.913149e-01 | 0.228 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.913149e-01 | 0.228 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.913149e-01 | 0.228 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 5.913149e-01 | 0.228 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 5.913149e-01 | 0.228 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 5.913149e-01 | 0.228 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 5.918819e-01 | 0.228 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.918819e-01 | 0.228 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.918819e-01 | 0.228 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.957769e-01 | 0.225 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 5.957769e-01 | 0.225 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.008087e-01 | 0.221 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.061314e-01 | 0.217 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 6.061314e-01 | 0.217 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.061314e-01 | 0.217 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 6.061314e-01 | 0.217 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 6.061314e-01 | 0.217 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 6.061314e-01 | 0.217 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 6.061314e-01 | 0.217 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 6.080544e-01 | 0.216 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.101378e-01 | 0.215 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.192578e-01 | 0.208 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.192578e-01 | 0.208 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 6.228960e-01 | 0.206 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.228960e-01 | 0.206 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.248911e-01 | 0.204 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.248911e-01 | 0.204 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.248911e-01 | 0.204 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.311831e-01 | 0.200 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.353146e-01 | 0.197 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.388635e-01 | 0.195 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.388635e-01 | 0.195 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.388635e-01 | 0.195 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.388635e-01 | 0.195 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.403674e-01 | 0.194 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.403674e-01 | 0.194 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.403674e-01 | 0.194 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.403674e-01 | 0.194 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 6.403674e-01 | 0.194 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.403674e-01 | 0.194 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 6.403674e-01 | 0.194 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.403674e-01 | 0.194 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.403674e-01 | 0.194 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.403674e-01 | 0.194 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.403674e-01 | 0.194 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.403674e-01 | 0.194 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 6.403674e-01 | 0.194 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 6.403674e-01 | 0.194 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.403674e-01 | 0.194 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.403674e-01 | 0.194 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.412487e-01 | 0.193 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.420920e-01 | 0.192 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.453563e-01 | 0.190 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.453563e-01 | 0.190 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.453563e-01 | 0.190 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.453563e-01 | 0.190 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.453563e-01 | 0.190 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.479319e-01 | 0.188 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.521552e-01 | 0.186 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.521552e-01 | 0.186 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.534146e-01 | 0.185 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.534146e-01 | 0.185 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.534146e-01 | 0.185 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.547921e-01 | 0.184 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.639670e-01 | 0.178 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.689542e-01 | 0.175 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.694151e-01 | 0.174 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.694151e-01 | 0.174 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 6.694151e-01 | 0.174 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 6.694151e-01 | 0.174 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.694151e-01 | 0.174 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.702623e-01 | 0.174 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.747295e-01 | 0.171 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 6.768049e-01 | 0.170 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.771547e-01 | 0.169 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.782765e-01 | 0.169 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.782765e-01 | 0.169 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.810068e-01 | 0.167 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.835348e-01 | 0.165 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.835348e-01 | 0.165 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.835348e-01 | 0.165 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.835348e-01 | 0.165 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.835348e-01 | 0.165 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.835348e-01 | 0.165 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.835348e-01 | 0.165 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 6.835348e-01 | 0.165 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.835348e-01 | 0.165 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.852215e-01 | 0.164 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.869311e-01 | 0.163 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.869311e-01 | 0.163 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 6.869311e-01 | 0.163 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.908640e-01 | 0.161 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.936672e-01 | 0.159 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.936672e-01 | 0.159 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.978382e-01 | 0.156 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.978382e-01 | 0.156 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.978382e-01 | 0.156 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.978382e-01 | 0.156 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 6.978382e-01 | 0.156 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 6.978382e-01 | 0.156 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.978382e-01 | 0.156 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.987818e-01 | 0.156 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.138206e-01 | 0.146 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.145735e-01 | 0.146 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.158852e-01 | 0.145 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.158852e-01 | 0.145 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.158852e-01 | 0.145 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 7.158852e-01 | 0.145 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.158852e-01 | 0.145 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.162319e-01 | 0.145 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.162319e-01 | 0.145 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.162319e-01 | 0.145 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.162319e-01 | 0.145 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.190992e-01 | 0.143 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 7.215230e-01 | 0.142 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 7.215230e-01 | 0.142 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 7.215230e-01 | 0.142 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.215230e-01 | 0.142 | 0 | 0 |
| Mitochondrial ABC transporters | R-HSA-1369007 | 7.215230e-01 | 0.142 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 7.215230e-01 | 0.142 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.215230e-01 | 0.142 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 7.215230e-01 | 0.142 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 7.215230e-01 | 0.142 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.215230e-01 | 0.142 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.215230e-01 | 0.142 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.232104e-01 | 0.141 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.242034e-01 | 0.140 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.242034e-01 | 0.140 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 7.242034e-01 | 0.140 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.242034e-01 | 0.140 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 7.319660e-01 | 0.136 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.331015e-01 | 0.135 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.331015e-01 | 0.135 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.331015e-01 | 0.135 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.331015e-01 | 0.135 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.368333e-01 | 0.133 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.368333e-01 | 0.133 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.368333e-01 | 0.133 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.368333e-01 | 0.133 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.373659e-01 | 0.132 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.406829e-01 | 0.130 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 7.485951e-01 | 0.126 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.485951e-01 | 0.126 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 7.485951e-01 | 0.126 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.489435e-01 | 0.126 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 7.493470e-01 | 0.125 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.493470e-01 | 0.125 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.507096e-01 | 0.125 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.507096e-01 | 0.125 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.507096e-01 | 0.125 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.510075e-01 | 0.124 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.549530e-01 | 0.122 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.549530e-01 | 0.122 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.549530e-01 | 0.122 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.549530e-01 | 0.122 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.549530e-01 | 0.122 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.549530e-01 | 0.122 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.549530e-01 | 0.122 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.549530e-01 | 0.122 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.549530e-01 | 0.122 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.549530e-01 | 0.122 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.563383e-01 | 0.121 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.565386e-01 | 0.121 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.565386e-01 | 0.121 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.565386e-01 | 0.121 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.674113e-01 | 0.115 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.705105e-01 | 0.113 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.711072e-01 | 0.113 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 7.711072e-01 | 0.113 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.711072e-01 | 0.113 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 7.711072e-01 | 0.113 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.711072e-01 | 0.113 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 7.733549e-01 | 0.112 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.750347e-01 | 0.111 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.750347e-01 | 0.111 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.750347e-01 | 0.111 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.750347e-01 | 0.111 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.767540e-01 | 0.110 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.791184e-01 | 0.108 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.832239e-01 | 0.106 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.832239e-01 | 0.106 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.832239e-01 | 0.106 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.843717e-01 | 0.105 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.843717e-01 | 0.105 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.843717e-01 | 0.105 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.843717e-01 | 0.105 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.843717e-01 | 0.105 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.843717e-01 | 0.105 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.843717e-01 | 0.105 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.843717e-01 | 0.105 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.843717e-01 | 0.105 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.843717e-01 | 0.105 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.843717e-01 | 0.105 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.843717e-01 | 0.105 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.888656e-01 | 0.103 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.918393e-01 | 0.101 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.918393e-01 | 0.101 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.918393e-01 | 0.101 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.918393e-01 | 0.101 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.918393e-01 | 0.101 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.923607e-01 | 0.101 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.923607e-01 | 0.101 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.923607e-01 | 0.101 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.981688e-01 | 0.098 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.020103e-01 | 0.096 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.100937e-01 | 0.091 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.102600e-01 | 0.091 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.102600e-01 | 0.091 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 8.102600e-01 | 0.091 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 8.102600e-01 | 0.091 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 8.102600e-01 | 0.091 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.102600e-01 | 0.091 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.102600e-01 | 0.091 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 8.102600e-01 | 0.091 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.108943e-01 | 0.091 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.108943e-01 | 0.091 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.115946e-01 | 0.091 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.122699e-01 | 0.090 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.182780e-01 | 0.087 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.222275e-01 | 0.085 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.255538e-01 | 0.083 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.283760e-01 | 0.082 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.283760e-01 | 0.082 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.330415e-01 | 0.079 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 8.330415e-01 | 0.079 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.330415e-01 | 0.079 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.330415e-01 | 0.079 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.330415e-01 | 0.079 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.330415e-01 | 0.079 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.330415e-01 | 0.079 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.330415e-01 | 0.079 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.330415e-01 | 0.079 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.375290e-01 | 0.077 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.377643e-01 | 0.077 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.377643e-01 | 0.077 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.377643e-01 | 0.077 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.380486e-01 | 0.077 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.380486e-01 | 0.077 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.401901e-01 | 0.076 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.413172e-01 | 0.075 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.420772e-01 | 0.075 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.484450e-01 | 0.071 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.508674e-01 | 0.070 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.530889e-01 | 0.069 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.530889e-01 | 0.069 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.530889e-01 | 0.069 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.530889e-01 | 0.069 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.530889e-01 | 0.069 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.556071e-01 | 0.068 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.569177e-01 | 0.067 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.590293e-01 | 0.066 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.590293e-01 | 0.066 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 8.590293e-01 | 0.066 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.607913e-01 | 0.065 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.707301e-01 | 0.060 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.707301e-01 | 0.060 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.707301e-01 | 0.060 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 8.707301e-01 | 0.060 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.707301e-01 | 0.060 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.707301e-01 | 0.060 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 8.707301e-01 | 0.060 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.707301e-01 | 0.060 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 8.707301e-01 | 0.060 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 8.707301e-01 | 0.060 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.707301e-01 | 0.060 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.711013e-01 | 0.060 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.713161e-01 | 0.060 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.723999e-01 | 0.059 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 8.723999e-01 | 0.059 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 8.723999e-01 | 0.059 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.723999e-01 | 0.059 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.751161e-01 | 0.058 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.807460e-01 | 0.055 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.807460e-01 | 0.055 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.845933e-01 | 0.053 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.845933e-01 | 0.053 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.845933e-01 | 0.053 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.847812e-01 | 0.053 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.847812e-01 | 0.053 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.847812e-01 | 0.053 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.847812e-01 | 0.053 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.862539e-01 | 0.052 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.862539e-01 | 0.052 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.862539e-01 | 0.052 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.862539e-01 | 0.052 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.944527e-01 | 0.048 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.999142e-01 | 0.046 | 0 | 0 |
| Transport of fatty acids | R-HSA-804914 | 8.999142e-01 | 0.046 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.999142e-01 | 0.046 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.999142e-01 | 0.046 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.999142e-01 | 0.046 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 8.999142e-01 | 0.046 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.999142e-01 | 0.046 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.999142e-01 | 0.046 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.999142e-01 | 0.046 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.999142e-01 | 0.046 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.025897e-01 | 0.045 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.037233e-01 | 0.044 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.058030e-01 | 0.043 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.058030e-01 | 0.043 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.058030e-01 | 0.043 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.058030e-01 | 0.043 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.058030e-01 | 0.043 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.058030e-01 | 0.043 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.082025e-01 | 0.042 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.116343e-01 | 0.040 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 9.119347e-01 | 0.040 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 9.119347e-01 | 0.040 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.119347e-01 | 0.040 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.119347e-01 | 0.040 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 9.119347e-01 | 0.040 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.119347e-01 | 0.040 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.149852e-01 | 0.039 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.149852e-01 | 0.039 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.149852e-01 | 0.039 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.149852e-01 | 0.039 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.158964e-01 | 0.038 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.170795e-01 | 0.038 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.225121e-01 | 0.035 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.225121e-01 | 0.035 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.225121e-01 | 0.035 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.225121e-01 | 0.035 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 9.225121e-01 | 0.035 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 9.225121e-01 | 0.035 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.225121e-01 | 0.035 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.225121e-01 | 0.035 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 9.225121e-01 | 0.035 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.231236e-01 | 0.035 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.233212e-01 | 0.035 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.233212e-01 | 0.035 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.233212e-01 | 0.035 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.262345e-01 | 0.033 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.264014e-01 | 0.033 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.287738e-01 | 0.032 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.308819e-01 | 0.031 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.308819e-01 | 0.031 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 9.318197e-01 | 0.031 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.318197e-01 | 0.031 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.318197e-01 | 0.031 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.318197e-01 | 0.031 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.318197e-01 | 0.031 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.318197e-01 | 0.031 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.318197e-01 | 0.031 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.318197e-01 | 0.031 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.318197e-01 | 0.031 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.318197e-01 | 0.031 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.318197e-01 | 0.031 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.340509e-01 | 0.030 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.364257e-01 | 0.029 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.385895e-01 | 0.028 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.385895e-01 | 0.028 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.400097e-01 | 0.027 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.400097e-01 | 0.027 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.400097e-01 | 0.027 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.400097e-01 | 0.027 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.400097e-01 | 0.027 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.413727e-01 | 0.026 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.435662e-01 | 0.025 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.439365e-01 | 0.025 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.439365e-01 | 0.025 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.455387e-01 | 0.024 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 9.472163e-01 | 0.024 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.472163e-01 | 0.024 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.475009e-01 | 0.023 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.475009e-01 | 0.023 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.480258e-01 | 0.023 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.490047e-01 | 0.023 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.490047e-01 | 0.023 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.490047e-01 | 0.023 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.490047e-01 | 0.023 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.495484e-01 | 0.022 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.516867e-01 | 0.022 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 9.535576e-01 | 0.021 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 9.535576e-01 | 0.021 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.535576e-01 | 0.021 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.535576e-01 | 0.021 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.535576e-01 | 0.021 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.535576e-01 | 0.021 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.535717e-01 | 0.021 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.535717e-01 | 0.021 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.539411e-01 | 0.020 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.577539e-01 | 0.019 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.591374e-01 | 0.018 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.591374e-01 | 0.018 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.591374e-01 | 0.018 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.640471e-01 | 0.016 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.640471e-01 | 0.016 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.640471e-01 | 0.016 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.640471e-01 | 0.016 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.640471e-01 | 0.016 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.640471e-01 | 0.016 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.650798e-01 | 0.015 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.670733e-01 | 0.015 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.670733e-01 | 0.015 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.670733e-01 | 0.015 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.683671e-01 | 0.014 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.683671e-01 | 0.014 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.683671e-01 | 0.014 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.683671e-01 | 0.014 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.683671e-01 | 0.014 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.686980e-01 | 0.014 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.702201e-01 | 0.013 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.704256e-01 | 0.013 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.704381e-01 | 0.013 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.721683e-01 | 0.012 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.721683e-01 | 0.012 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 9.721683e-01 | 0.012 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.721683e-01 | 0.012 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.721683e-01 | 0.012 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.721683e-01 | 0.012 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 9.721683e-01 | 0.012 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.727853e-01 | 0.012 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.734699e-01 | 0.012 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.734699e-01 | 0.012 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.738444e-01 | 0.012 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.738444e-01 | 0.012 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.738444e-01 | 0.012 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.755129e-01 | 0.011 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.755129e-01 | 0.011 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.755129e-01 | 0.011 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.755129e-01 | 0.011 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.756273e-01 | 0.011 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.762002e-01 | 0.010 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.769887e-01 | 0.010 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.784557e-01 | 0.009 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.784557e-01 | 0.009 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.784557e-01 | 0.009 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.805797e-01 | 0.009 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.808684e-01 | 0.008 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.809715e-01 | 0.008 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.810450e-01 | 0.008 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.810450e-01 | 0.008 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.810450e-01 | 0.008 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.810450e-01 | 0.008 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.827635e-01 | 0.008 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.829325e-01 | 0.007 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.833233e-01 | 0.007 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.833233e-01 | 0.007 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.833233e-01 | 0.007 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.846426e-01 | 0.007 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.853278e-01 | 0.006 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.862423e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.862475e-01 | 0.006 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.885003e-01 | 0.005 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.886433e-01 | 0.005 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.900086e-01 | 0.004 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.900086e-01 | 0.004 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.901424e-01 | 0.004 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.901424e-01 | 0.004 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.906898e-01 | 0.004 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.908522e-01 | 0.004 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.912099e-01 | 0.004 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.912625e-01 | 0.004 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.914782e-01 | 0.004 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.920975e-01 | 0.003 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.920975e-01 | 0.003 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.922667e-01 | 0.003 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.929525e-01 | 0.003 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.931966e-01 | 0.003 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.931966e-01 | 0.003 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.943727e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.951299e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.952938e-01 | 0.002 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.953677e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.953677e-01 | 0.002 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.954839e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.955111e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.957496e-01 | 0.002 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.959249e-01 | 0.002 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.959828e-01 | 0.002 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.964150e-01 | 0.002 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.964150e-01 | 0.002 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.964225e-01 | 0.002 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.968462e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.970350e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.972031e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.972309e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.972405e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.974827e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.974827e-01 | 0.001 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.975593e-01 | 0.001 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.975593e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.979879e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.983047e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.983525e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.983940e-01 | 0.001 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.985385e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.986541e-01 | 0.001 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.987143e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.987143e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.988690e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.988690e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.989880e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.990545e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.991249e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.992147e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.992302e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.992855e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.992855e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.992871e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.993229e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.993639e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.993639e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.994021e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.994044e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.994710e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.994761e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.995610e-01 | 0.000 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.996434e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.997241e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.997574e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.997742e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.998028e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.998124e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.998345e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998440e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.998548e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.998877e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999012e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.999012e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999029e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999320e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999328e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999380e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999543e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999557e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999574e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.999598e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999598e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999646e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999708e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999726e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999836e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999856e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999889e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999889e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999899e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999953e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999958e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999970e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999978e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999978e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999980e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999982e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999983e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999986e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999989e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999989e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999990e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999991e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999993e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999994e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999995e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999996e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999996e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999996e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999998e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999999e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999999e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |